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ABSTRACT
Common fragile sites, which are areas of the genome prone to breaks under replication stress,
are frequently altered in tumor cells. Two hypotheses have been proposed to explain why
common fragile sites break: (1) AT-rich segments with high flexibility in the fragile site fold
into secondary structures, leading to replication fork stalling and chromosomal breakage, and
(2) Fragile site regions lack sufficient origins of replication, which paired with replication
stress results in failure to complete replication before mitosis and eventual breakage of
unreplicated DNA. To test these hypotheses, we mapped 30 break locations in each of two
yeast artificial chromosomes (YACs) containing human DNA inserts from fragile sites
FRA3B and FRA7H. We compared break locations with the locations of high flexibility
regions and potential origins. Breaks in both FRA3B and FRA7H are located far from
potential origins. These data support the second hypothesis. Breaks in FRA3B, but not
FRA7H, are located near high flexibility regions. Thus, secondary structure formation may
contribute to breakage in FRA3B but is unlikely to contribute to breakage in FRA7H.
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Chapter 1
Introduction and Background
1.1 Fragile sites
Normal cellular processes involve replication of DNA for cell division. During this
DNA replication period, DNA damage can result. If not repaired correctly, DNA damage can
lead to alterations that can have adverse affects on the organism. Such DNA alterations can
result from DNA double-stranded breaks (DSB) that can lead to translocation, amplification,
and deletion of DNA (Chung et al., 2010; O’Keefe and Richards, 2006; Smith et al., 2007).
Specific areas of DNA are prone to such DNA alterations when cells are placed under
replication stress. Replication stress can result when inhibition of DNA polymerase
production leads to a lack of replication machinery available (Ikegami et al., 1978; Wist and
Prydz, 1979). Stress can also occur when reagents such as dNTP pools are inhibited,
resulting in a lack of raw materials needed to complete replication. Areas within the genome
that are prone to breakage under replication stress have been classified as “fragile sites” and
can be identified as recurrent sites of gaps and breaks on metaphase chromosomes (Glover et
al., 2005). Fragile sites have been divided into two main categories, “common” and “rare,”
based on their frequency in the population and mode of induction.
1.2 Rare Fragile Sites
Rare fragile sites resulting from short tandem repeat (STRs) expansion mutations, are
passed from parent to offspring following normal Mendelian patterns of inheritance, and
occur in less than 5% of the human population (Kremer et al., 1991; Sutherland et al., 1998).
Repeat expansion mutations result when DNA slippage during replication results in loop out
structures that contain repeated sequences while the two strands of DNA still maintain
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complementary base-pairing. This will result in an increased number of repeats if loop out
structures occur on the daughter strands during DNA replication (Richards and Sutherland,
1997). Some rare fragile sites have direct ties to genetic disorders. For example, fragile-X
syndrome, responsible for X-linked mental retardation, results from overall instability of a
region on chromosome X caused by the expansion of CGG repeats at fragile site FRAXA
and abnormal methylation within the area (Devys et al., 1993). This instability and
methylation results in lower transcription of the FMR1 gene located within this same area.
Lower levels of Fmr1 in the brain leads to the symptoms of fragile-X syndrome (Devys et al.,
1993). Rare fragile sites can be divided into two subclasses, the folate-sensitive and nonfolate-sensitive rare fragile sites. Folate-sensitive rare fragile sites break under replication
stress caused when dNTP pools needed for DNA synthesis are severely depleted due to lack
of folate (Sutherland, 1979). Breakage at folate-sensitive rare fragile sites is due to an
expansion of a tri-nucleotide microsatellite (Sutherland, 1991). Expanded tri-nucleotide
microsatellites permit hairpin structure formation and other non B-DNA structures due to the
repeat’s ability to self-pair while single stranded. These secondary structures can block
replication forks and result in DNA breakage (Aguilera and Gómez-González, 2008; Gacy et
al., 1995; Wells, 1996). Examples of tri-nucleotide expansions are (CGG)n linked with
Fragile X syndrome (Devys et al., 1993), (CCG)n linked with Fragile X-E syndrome (Gecz,
2000) and (CAG)n linked to Huntington’s Disease (Walker, 2007). Non-affected individuals
have a limited repeat sequence up to 50 copies, whereas individuals with the rare fragile site
have 200 or more copies of the repeat (Schwartz et al., 2006). Examples of folate-sensitive
rare fragile sites are FRAXA and FRAXE, responsible for aberrations of FMR1 and FMR2,
respectively. The non-folate-sensitive sub-class of rare fragile sites usually consists of
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expansions of AT repeat microsatellites (Sutherland et al., 1998). Unaffected individuals
contain 7-12 copies of the dinucleotide repeat, while individuals that have breaks at a nonfolate-sensitive rare fragile site can contain greater than 2000 copies of the sequence
(Debacker and Kooy, 2007). These sites are also sensitive to distamycin A, a drug that
incorporates into the DNA minor groove and disrupts placement of transcription factors, and
to bromodeoxyuridine (BrdU), a thymidine analog that incorporates into fragile site regions
(Bellorini et al., 1995; Sutherland et al., 1985). The mechanism for DNA breakage due to
AT repeat expansion follows the same principles as the tri-nucleotide repeat expansion.
Long stretches of AT repeats can base pair with one another while single stranded, forming
stable non B-DNA structures that can block replication fork progression and result in breaks
(Aguilera and Gómez-González, 2008; Wells, 1996).
1.3 Common Fragile Sites
In contrast with rare fragile sites, common fragile sites are present in every human as
a part of normal human chromosomes (Glover et al., 1984). Not only have these sites been
identified in humans, but orthologs have been identified in primates, cats, dogs, and mice.
Yeast also contain fragile site-like sequences, suggesting an evolutionary significance
(Durkin and Glover, 2007). Common fragile sites are somewhat AT-rich but do not contain
expansions of specific repeated sequences seen in rare fragile sites (Debacker and Kooy,
2007). Common fragile site breakage has been identified after treatment with low doses of
hydroxyurea or aphidicolin (Glover et al., 2005). Treatments with aphidicolin specifically
cause breaks within fragile site regions. Hydroxyurea also causes breaks within fragile site
regions, but breaks also result in other random locations. Both aphidicolin and hydroxyurea
inhibit DNA synthesis. Hydroxyurea acts by inhibiting the enzyme ribonucleotide reductase.
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Ribonucleotide reductase reduces ribonucleoside diphosphates to deoxyribonucloside
diphosphates. The inhibition of this enzyme by hydroxyurea decreases the available
nucleotide diphosphate pools needed for sufficient DNA replication (Kihlman and Natarajan,
1984; Kunz, 1988). Aphidicolin is a tetracyclic diterpene antibiotic used in cancer
chemotherapy that inhibits an array of human DNA polymerases responsible for DNA
replication. Aphidicolin primarily inhibits DNA polymerase alpha, which is the primase
enzyme used in DNA replication. Reduced primase enzyme activity results in longer gaps
between initiation events on the lagging strand during DNA replication (Ikegami et al., 1978;
Wist and Prydz, 1979). Aphidicolin also inhibits polymerases delta and epsilon. These two
polymerases play a progressive replication role with addition of nucleotide bases but also
contain 3’ to 5’ exonuclease activity. Aphidicolin competes with dNTPs for delta and
epsilon subunit binding and can inhibit both polymerase mechanisms (Cheng and Kuchta,
1993; Goscin and Byrnes, 1982). Aphidicolin inhibition of polymerase alpha and delta is 6
to 10 times more selective than that of polymerase epsilon (Wright et al., 1994). Polymerases
beta and gamma are insensitive to the drug (Wist and Prydz, 1979). This decrease in DNA
replication due to DNA polymerase inhibition can result in stalling of replication forks and
eventual DNA strand breakage (Dhillon et al., 2003). The hypotheses describing the
mechanism for common fragile site breakage will be discussed below.
1.4 Common Fragile Site Breakage and Tumorigenesis
DNA damage leading to mutations that drive cancer development can result from
external factors such as UV radiation, ionizing radiation, and chemotherapy and from
endogenous factors such as reactive oxygen species (Jackson, 2002). Chromosomal
aberrations at common fragile sites are another endogenous source of DNA damage, leading
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to deletions, translocations, and amplifications. Because these aberrations are observed in a
variety of newly proliferating cancer cells (Durkin et al., 2008; O’Keefe and Richards, 2006),
common fragile site breakage potentially plays a role in tumor initiation. Burrow et al. (2009)
used database information on 444 unique pairs of genes involved in cancer-specific recurrent
translocations. Of the translocation gene pairs investigated, 52% had at least one gene
located within or alongside a known fragile site (Burrow et al., 2009). Homozygous
deletions in cells extracted from tumors were also commonly mapped within fragile sites
(Bignell et al., 2010). Homozygous deletions within cancer cells that could not be explained
by the presence of a recessive cancer gene could now be explained due to fragile site
breakage.
Three main common fragile sites have been studied with their role in tumor
progression: FRA3B and FRA16D, which are located within tumor suppressor genes FHIT
and WWOX, respectively, and FRA7G, which is located near the MET oncogene.
A. FRA3B and the FHIT tumor suppressor gene.
The Fragile Histidine Triad (FHIT) gene is 1.5 Mb in size, located on the left arm of
chromosome 3 (3p14.2). FRA3B, a well-known common fragile site of about 500 kb in
length, extends from FHIT exon 3 to approximately 30 kb centromere distal of FHIT exon 5
(Zimonjic et al., 1997). FRA3B is the most frequently broken common fragile site in
lymphoblasts following aphidicolin treatment (Markkanen et al., 1982). Breaks in the
FRA3B fragile site are the most likely cause of deletions in the FHIT gene observed in
cancer cells (Inoue et al., 1997). The FHIT gene is absent or aberrant in up to 50% of earlystage esophageal, stomach, and colon carcinomas (Ohta et al., 1996). These changes in early
stage tumors suggest that FRA3B instability could be driving cancer development. If
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mutations within the FHIT gene were observed later in tumorigenesis, such alterations could
be a consequence of general genetic instability in tumors. Observing FHIT inhibition early
within tumor formation provides the evidence that fragile site instability plays a role in
cancer progression. The tumor suppressor capabilities of the FHIT gene are due to its
encoding of bis(5'-adenosyl)-triphosphatase, a protein that hydrolyzes the AP3A and AP4A
proteins that have been identified to regulate DNA replication and stress signal responses
(Barnes et al., 1996). The FHIT gene also works in coordination with the UBC9 protein.
The UBC9 protein has a direct role in regulation of S- and M-phase cyclins, proteins that
interact in cell cycle progression. Therefore FHIT works with UBC9 in partnership to
maintain cell cycle function (Shi et al., 2000). Most recently, FHIT was identified as a
regulator of thymidine kinase 1 expression and thymidine triphosphate pool levels. Loss of
FHIT leads to decreased replication fork progression and increased genome instability
(Saldivar et al., 2012).
B. FRA16D and the WWOX tumor suppressor gene.
The WW Domain-containing Oxidoreductase (WWOX) gene is 1.1Mb in size located
at 16q23.2 on chromosome 16. WWOX includes the 270 kb common fragile site FRA16D
located within the 780 kb intron 8 of WWOX (Ried et al., 2000). FRA16D is the second-most
breakable common fragile site in lymphoblasts through aphidicolin treatment (Durkin and
Glover, 2007). WWOX codes for a protein that contains two WW domains coupled to a
region with high homology to the short-chain dehydrogenase/reductase (SRD) family of
enzymes (Bednarek et al., 2000). The mouse ortholog of WWOX, the mouse Wox1 protein,
is an essential mediator of tumor necrosis factor-alpha-induced apoptosis. The conservation
between the Homo sapiens WWOX gene and the Mus musculus WOX1 is approximately 93%,
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which suggests a similar cell signaling pathway leading to apoptosis in both organisms.
Many translocation breakpoints in multiple melanomas and deletions within cancer cell lines
occur within or near FRA16D (Krummel et al., 2000; Mangelsdorf et al., 2000). WWOX
aberrations have been identified in about 60% of breast, hematopoietic, bladder, and lung
cancers (Aqeilan et al., 2004; Guler et al., 2005; Iliopoulos et al., 2005; Ishii and Furukawa,
2004). Ectopic expression of WWOX within new breast cancer cells suppresses tumor growth
compared to ectopic expression of mutated mRNA sequences of WWOX (Bednarek et al.,
2000). This evidence showed that aberrant or absent WWOX gene expression plays a direct
role in tumor cell progression. Loss of heterozygosity (LOH) at FRA16D has been identified
in 33% of Barrett’s Esophageal cells, which are a premalignant intermediate to esophageal
adenocarcinoma (Lai et al., 2010). Deletion analysis of a primary carcinoma and of a
secondary metastasis of the same carcinoma showed deletion endpoints that were located
precisely within the FRA16D location despite instability throughout the genome (Finnis et
al., 2005). Loss of FRA16D in precancerous and early cancerous cell lines suggests that it
plays an early and causative role in early tumorigenesis.
C. FRA7G and the MET oncogene.
The FRA7G fragile site is approximately 300 kb in size and is located at 7q31.2 on
chromosome 7 (Huang et al., 1998). Frequent loss of heterozygosity (LOH) at the region
where FRA7G is located has been identified in tumor cells associated with prostate, ovarian,
and thyroid cancers (Huang et al., 1999; Jenkins et al., 1998; Zhang et al., 1998). FRA7G
breakage can induce large amplifications that include the MET oncogene (Han et al., 2003;
Hellman et al., 2000; Miller et al., 2005). MET encodes a cell surface receptor for hepatocyte
growth factor ligand (HGF) (Bottaro et al., 1991). Amplification of this oncogene can result
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in increased tumorigenesis rates due to increased proliferation, scattering, morphogenesis,
and survival of cells. Microarray analysis of primary esophageal adenocarcinomas showed
amplification of MET gene, with boundaries of the amplicons located at FRA7G (Miller et
al., 2006). These amplifications appear to result from breakage-fusion bridge cycles after
DNA breakage (Toledo et al., 1992). This identification of early MET gene amplification
within primary adenocarcinomas suggests that the amplification drives early tumorigenesis.
Taking these examples of tumorigenesis into account, identifying a mechanism for
common fragile site instability is essential due to its relatedness with chromosomal
aberrations directly leading to loss of tumor suppressor gene function or with amplification
of oncogene function leading to cancer initiation.
1.5 Potential Mechanisms for Fragile Site Breakage
Less is understood about the mechanism of common fragile site breakage under
replication stress compared to rare fragile site breakage. Common fragile sites range in size
from 100 kb to approximately 1 Mb, and the specific locations within these fragile sites
where breaks occur in individual cells has not been well mapped (Durkin and Glover, 2007).
Several hypotheses have been developed to explain why fragile sites are unstable and prone
to breaks under conditions where replication is partially inhibited.

Proposed Hypothesis #1: Fragility of the region is due to secondary structure formation by
specific sequences at the site. Areas of high flexibility and high torsion known as “flexibility
peaks” are prevalent in fragile site regions (Mishmar et al., 1998). The flexibility of a region
directly correlates to the sequence. Flexibility can be described based on the twist angles
present between each dinucleotide base step. AT base steps have higher twist angles than
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GC base steps. Each purine-pyrymidine dinucleotide base step (AC(TG), CA(GT)) has a
higher twist angle than a homo-nucleotide base step (TC(GA), CT(AG) AA(TT), GG(CC)).
Areas of high flexibility and torsion are those that contain average twist angles much greater
than the average of the region, and these areas may have greater potential for intra-strand
secondary structure formation (Sarai et al., 1989). During replication stress, large segments
of single stranded DNA on either strand at the replication fork can self-pair and form hairpinlike secondary structures. Larger segments of ssDNA can result due to an uncoupling of the
DNA helicase and polymerase. This uncoupling can be the result of a lack of polymerase
available to add primers on the lagging strand (polymerase alpha) or lack of polymerase
available for addition of nucleotides (polymerase delta and epsilon). Uncoupling could also
result from decreased dNTP pools, slowing the rate of polymerase activity compared to
helicase unwinding. AT-rich “flexibility peak” regions can form these hairpin structures
(Figure 1). The secondary structures cause replication fork stalling and may be cleaved by
cellular nucleases, resulting in a break (Durkin and Glover, 2007; Lemoine et al., 2005).
Secondary structure formation resulting from long stretches of single-stranded DNA could
result in several different break characteristics. Replication along the strand containing the
secondary structure could fail to replicate the region where the structure resided. After
replication of the area was complete, the resulting new double-stranded DNA molecule
would contain a single stranded gap from where the secondary structure was not replicated
(Figure 2). This single stranded gap could be cleaved by a nuclease resulting in a two-ended
double-stranded break (Figure 2B), or replication could stall due to secondary structure. A
nuclease could cleave the secondary structure, resulting in a break. This cleavage would
result in a one-ended double-stranded break (Figure 3A). However, if a nearby origin were
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available in the area to replicate from the opposite direction, the process would result in a
two-ended double-stranded break (Figure 3B).

	
  

	
  

Figure	
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Figure 2. Breaks resulting from a skipping of replication of the secondary structure
during DNA replication. (A) Skipping of secondary structure replication will result in a
single stranded gap. (B) The single stranded gap may be cleaved by nuclease activity and
create a two-ended double stranded break, or the break could result from mechanical
forces.
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Figure 3. Double stand breaks resulting from nuclease activity cleaving the secondary
structure. (A) Cleavage of a secondary structure during replication results in one-ended
double stranded breaks. (B) Convergence of replication from a nearby origin will result
in a two-ended double-strand breaks.

Proposed Hypothesis #2: Fragility of the region is due to the inability of replication to be
completed during S phase due to the lack of origins available (Figure 4). Fragile sites contain
fewer origin sites than non-fragile regions. Under conditions of normal replication, both
fragile and non-fragile regions are able to complete replication. Under conditions of
replication stress, non-fragile regions fire previously unused origins to help complete the
replication process. Fragile site regions do not activate additional origins to help complete
replication (Letessier et al., 2011; Ozeri-Galai et al., 2011). DNA breaks can form due to the
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breakage of anaphase bridges that result due to the inability of DNA to finish replication
before mitosis begins (Chan et al., 2009).

Figure 4. Mechanism for double stranded DNA breakage due to lack of origins available in
fragile
site region. (A) Left. Non-fragile regions complete DNA synthesis under normal
	
  
replication conditions. Right. Under replication stress conditions, non-fragile regions fire
more origins of replication to help complete the replication process before the end of S-phase.
(B) Left. Fragile site regions contain fewer origins for DNA replication compared to nonfragile regions, but complete DNA synthesis under normal replication conditions. Right.
Fragile site regions do not activate additional origins of replication to help finish DNA
replication when placed under replication stress. Breaks result when non-replicated DNA
tries to divide during mitosis. Black circles represent origins of replication. Gray lines
represent un-replicated DNA and black lines with arrows represent replicated DNA.

Proposed Hypothesis #3: Fragility of the region is due to the fact that fragile site regions lie
within a transition zone between early and late replicating segments of DNA (Figure 5). A
portion of the fragile site region may replicate early in S-phase, whereas nearby flanking
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DNA remains un-replicated until late S-phase. Replication forks that are paused in these
transition zones may collapse under replication stress, leading to breakage of the DNA
(Achkar et al., 2005; Palumbo et al.,2010). Alternatively, zones of replicated DNA close to
un-replicated DNA may be a preferential site for breakage (Cha and Kleckner, 2002).

Figure 5. Mechanism for double-stranded breaks that occur in between early and late
DNA replication transition zones. A portion of the fragile site will replicate early in Sphase. Flanking regions may not be replicated until late in S-phase. Replication forks
paused in the transition zones between the early and late replicating regions may be
prone to DNA breakage.
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Proposed Hypothesis #4: Fragility of the region is due to the fact that RNA and DNA
polymerases collide. Several common fragile sites lie within very large genes that take a
long time to transcribe. Transcription and replication can take place along a chromosome at
the same time; therefore, the RNA polymerase may collide with DNA polymerase involved
in DNA replication, resulting in fork collapse and breakage events (Figure 6) (Helmrich et
al., 2011).

Figure 6. Mechanism for single and double stranded breaks resulting from a
collision between a RNA polymerase II moving in one direction and DNA
replication helicase moving in the opposite direction. Collided RNA polymerase II
will allow formation of stable R-loop structures. Stalled DNA replication forks
could result in collapse and breakage.
These four hypotheses may not be mutually exclusive, and there is evidence to
suggest that a combination of these mechanisms could play a role in common fragile site
breakage. To date, Hypotheses 1 and 2 have a majority of supporting evidence. In evaluating
these mechanisms, Hypotheses 1 and 2 predict particular sequence characteristics at fragile
site break locations, whereas 3 and 4 do not. Therefore, research in the field has progressed,
trying to identify exact break locations within fragile site regions, to assess support for
Hypotheses 1 and 2. The major findings of this research to date are summarized below.
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1.6 Previous Research of Fragile Site Breakage
A. Research to Evaluate the Role of Secondary Structure in Break Formation
During replication stress, the DNA helicase can continue to unwind DNA, but due to
polymerase inhibition there will be a longer stretch of single-stranded DNA at the replication
fork. The sequence in fragile site regions will potentially pair with itself, resulting in a
secondary structure that further stalls replication and results in breaks. If replication stress
hinders DNA polymerase alpha in particular, this will result in a decrease in the primase
enzyme available. Since more primers are needed on the lagging strand, it is feasible that
secondary structures are more likely to occur in relation to the leading strand. Several
researchers have attempted to map the locations of breaks within fragile site regions and
compare these break sites to the location of structure-forming sequences. Zhang et al. (2007)
inserted a 500 bp region of FRA16D containing a known flexibility peak into a yeast
artificial chromosome (YAC). They observed more breaks occurring in YACs with this
sequence than in YACs that contained a control sequence insert, using the replication stress
of hydroxyurea (which reduces the dNTP pools). The study used hydroxyurea as a form of
replication stress rather than aphidicolin because yeast cells do not allow aphidicolin to cross
the cell wall, making this drug ineffective (Cooley and Mishra, 2000). Although the authors
determined that more breaks were forming in the sequence with the flexibility peak, they did
not analyze the exact locations where breaks were occurring within the context of the entire
FRA16D region. They therefore cannot completely conclude that flexibility peaks are the
primary cause of break formation. Burrow et al. (2010) studied the rare fragile site FRA16B,
which contains AT-rich repeat sequences. They identified secondary structures forming in
this fragile site after denaturation and reduplexing, and observed replication fork stalling at
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these regions, but were unable to determine whether the breaks within FRA16B were actually
located at the AT-rich sequence. The FRA16B sequence consisted of 14 identical copies of a
33 repeat AT-rich sequence. Although these data support the role of structure-forming
sequence in fragile site instability, this uniform AT richness is not representative of common
fragile site composition. Ragland et al. (2008) analyzed bacterial artificial chromosomes
(BACs) containing either a segment of FRA3B or a non-fragile human segment located on
chromosome 10. Both segments contained flexibility peak regions with characteristic
common fragile site AT-richness defined by twist angle. Both control and fragile site BAC
inserts contained stretches of consecutive AT repeats dispersed throughout the insert. The
BACs were inserted at ectopic sites in human chromosomes and analyzed for instability. The
inserted BACs with the FRA3B region showed instability while the control, non-fragile site
BACs did not. Thus, Ragland et al. (2008) concluded that the presence of AT-rich flexibility
peaks was not sufficient to cause breaks, and another variable must be present to cause
instability. Unfortunately, these authors were not able to determine the exact location that
the breaks were occurring within the inserted BACs; therefore, it is still not understood
whether the AT-rich flexibility peaks or another factor is causing the instability. Durkin et al.
(2008) used mouse cells containing a copy of human chromosome 3, which include FRA3B.
They mapped deletions within FRA3B and observed that most of these spanned introns 4 and
5 of the FHIT gene. Many deletion endpoints are in intron 5, in which 21 flexibility peaks
are located, although no deletions have exact endpoints at a flexibility peak. The deletions
result from repair of breaks that occurred within the specific region. Unfortunately, many
deletions were quite large; therefore, it is difficult to estimate the exact break location that
consequently created the deletion. Breaks could originate at the endpoints or in the middle of
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the sequence before deletion. Unlike previous studies, Dillon et al. (2013) took an in silico
approach, using the Mfold Web Server (Zuker, 2003) and statistical algorithms to analyze the
potential for secondary structure formation along human chromosome 10 and relate that to
fragile site regions. Analyzing 300 bp windows of genomic DNA from chromosome 10,
Dillon et al. (2013) concluded that the potential for more stable secondary structures was
located within areas that were highly GC-rich rather than those that were AT-rich. Their
analysis did not identify flexibility peaks in fragile sites as likely sites for secondary structure
formation. However, the 300 bp window is the length of the single stranded DNA during
normal replication; therefore, the authors failed to evaluate secondary structure
characteristics with larger segments of single stranded DNA that would be expected during
replication stress. Rajula (2011) addressed the specific problem of mapping exact break
locations in fragile site regions by using a yeast artificial chromosome (YAC) containing an
insert of human chromosome 3. This insert is 1.3 Mb in size, and it includes part of the FHIT
gene and most of FRA3B. The yeast strain containing this YAC was modified to disable
DNA repair mechanisms. Normally, DNA repair mechanisms resect DNA at a break to
expose a free, single-strand 3’ end that can be used to invade areas of homology. Therefore,
the template DNA for repair mechanisms can be quite far from the original break site (Gravel
et al., 2008; Mimitou and Symington, 2008; Zhu et al., 2008). Rajula (2011) aimed to
identify break locations in the fragile site region using a modified yeast strain with a
knockout of the gene EXO1. This gene creates a protein that uses 5’-3’ exonuclease activity
to resect DNA back from double-stranded breaks. Rajula identified YAC break locations in
23 strains and concluded that break sites were not located at or near flexibility peak areas.
However, this research is incomplete because the modified yeast strain still contains other
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exonucleases that could have resected break sites and because break locations were not
mapped to high resolution.
All of these studies aimed to identify whether secondary structure characteristics
play a role in fragile site instability. Burrow et al. (2010) found that secondary structure
formation did occur at fragile sites. But they used a rare fragile site with different sequence
characteristics and secondary structure forming capabilities. Zhang et al. (2007) found that
breaks occurred in regions that contained flexibility peaks. Durkin et al. (2008) found that
deletions were occurring predominately in areas that contained flexibility peak regions even
though they were not found specifically within the peaks themselves. These papers suggest
that flexibility peak regions do are involved in the breakage of fragile sites. On the other
hand, Ragland et al. (2008) showed that flexibility peaks alone may not be sufficient to cause
breaks within fragile sites, and Rajula (2011) found that breaks within the fragile sites
FRA3B were not occurring at flexibility peaks. Last, Dillon et al. (2013) suggest that the
most likely secondary structures would result from GC-rich areas, rather than AT-rich
flexibility peak regions.
B. Research to Evaluate the Role of Origin Paucity in Break Formation.
Fragile sites may contain fewer origins of replication sites than non-fragile areas.
Under normal replication conditions, both fragile and non-fragile site areas have enough time
and origin sites to complete DNA replication. Under conditions of replication stress, nonfragile areas (which already have greater numbers of origins) fire previously unused
additional origin sites to help replicate DNA when the process is slowed. Fragile site regions
do not fire additional origins, and mitosis can begin prior to the completion of DNA
replication, resulting in un-replicated DNA breaking during mitosis. Several researchers
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have identified origins and correlated them to break formation. Palakodeti et al. (2010)
evaluated the efficiency of initiation of four origin regions in a 50 kb segment from FRA3B.
In both replication stress and in normal replication conditions, the initiation efficiency of
these four origin sites within FRA3B was reduced compared to origin initiation within nonfragile areas elsewhere in the genome. Letessier et al. (2011) mapped origin initiation sites in
human B-lymphocytes. In both normal cells and cells under replication stress, there are
fewer origin initiation events within FRA3B than in non-fragile site regions. The authors did
not see fork stalling within FRA3B and thus concluded that instability in this region is
attributed to the long-travelling replication forks that may not complete DNA synthesis in the
fragile site region during S phase. Ozeri-Galai et al. (2011) determined average distances
between origins and found that under normal replication conditions, average distance
between origins in the fragile regions was less than that of the normal genome. This
suggested that more origins needed to be fired in order to complete fragile site replication
even under normal replication conditions. The researchers observed that average distance
between origins was reduced in normal genomic DNA under replication stress and therefore
concluded that more origins had fired, creating shorter distances between each origin to
compensate for the slowed replication. But in the common fragile site region of FRA16C,
average origin distance stayed the same even under replication stress, indicating that all
available origins were active. The authors determined average distances between fired origins
under replication stress and found the average distance in the fragile regions was larger than
that of the normal genome. Ozeri-Galai et al. (2011) also observed fork stalling near AT-rich
flexibility peaks, as identified by twist angle calculations (Sarai et al., 1989). These
flexibility peaks consisted of long runs of AT greater than 400 bp. The authors conclude that
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lack of origin firing along with replication stalling at particular sequences can be working
together to produce breaks within fragile regions.
Although all of these studies conclude that origin use is related to fragile site
instability, there is some disagreement between them. Letessier et al. (2011) and Ozeri-Galai
et al. (2011) suggest that under normal replication conditions, fragile site regions already
used all available origins, suggesting that these areas were hard to replicate. They added that
when placed under replication stress, no more origin sites were fired, suggesting that these
regions could not increase replication components to make up for decreased replication rates.
Letessier et al. (2011) and Ozeri-Galai et al. (2011) disagree on the role of secondary
structure formation increasing instability. Letessier et al. (2011) suggested that fragility in the
region was only due to long traveling replication forks that could not complete replication
during S phase. This is due to the fact that they did not see any replication fork stalling
during their experiments. Ozeri-Galai et al. (2011) disagree with this outcome, stating that
stalling does occur at AT-rich regions within the fragile site (determined by a decrease in
fork progression), and that a combination between lack of origins and stalling at secondary
structures works together to create instability within fragile sites.
1.7 Purpose of Study
Previous research in the field suggests two mechanisms of fragile site breakage.
Several studies indicate that secondary structure formation at predominantly AT-rich regions
within common fragile sites is likely. Replication forks can stall at such sites and collapse,
leading to breaks. Other studies provide evidence that a lack of origins and inability to
complete replication leads to break formation in common fragile sites. It is unclear whether
one or both of these mechanisms is the primary reason for fragile site breaks. Mapping the
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location of the breaks in fragile sites could help evaluate these mechanisms, because each
mechanism predicts particular break locations. The first mechanism would suggest that
breaks would locate near AT-rich regions, whereas the second mechanism would suggest that
breaks would locate far from origins. Common fragile sites are large regions of 100 kb –
1Mb. To date, there is insufficient evidence to answer the question of where breaks are
occurring within these common fragile site regions.
The purpose of my study was to address this gap in the literature by identifying the
break locations within fragile sites and to analyze these break locations to evaluate the
hypotheses that have been proposed to explain fragile site breaks. I mapped break locations
in fragile site regions using yeast artificial chromosomes (YACs) inserted into
Saccharomyces cerevisiae that contained an insert of DNA from human common fragile site
regions. I used two YACs, one with an insert from human FRA3B (located within the FHIT
tumor suppressor gene) and one with a human FRA7H insert (used to analyze the breakage
mechanism in a small fragile site). The use of yeast as my model organism had many
advantages, including (1) modification and mutation of the yeast genome to increase break
efficiency and identification was relatively easy; (2) yeast cell growth and division was fast,
allowing experiments to proceed quickly; (3) DNA replication in yeast was easily regulated,
allowing for induction of replication stress; (4) yeast contained the necessary components for
complete replication of the human DNA insert; and (5) by inserting a human segment into
yeast, a break in this segment would not result in any harm to the model organism. My
experimental strategy allowed me to map common fragile site break points more accurately
than previously described. Distinguishing and analyzing break regions in the FRA3B and
FRA7H fragile sites help us draw conclusions regarding the similarities between common
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fragile sites, specifically where these sites break. This research allows us to better evaluate
the two prominent hypotheses for why fragile sites break.
1.8 Hypotheses and Specific Aims
Based on the proposed mechanisms described above to explain breaks in common
fragile sites, I tested two hypotheses:
(1) If fragile site instability results from replication stalling at secondary structure, then we
will observe breaks near flexibility peaks in the FRA3B and FRA7H YACs.
(2) If fragile site instability results from lack of origin sites available to complete replication,
then we will observe breaks in regions that are furthest away from potential origins in both
YACs.
The research I completed to test these hypotheses consisted of four specific aims:
Aim 1. I genetically modified the yeast strain with the YAC carrying human DNA from
FRA3B, and the yeast strain with the FRA7H YAC, to make them useful in identification
and analysis of fragile site breaks.
Aim 2. I identified 30 yeast cells with a break in the FRA3B insert of the YAC, and 30 cells
with a break in the FRA7H insert of the YAC, and then narrowed the location of the break
region through PCR.
Aim 3. I performed telomere PCR on FRA7H and FRA3B inserts where the possible
location of break points had been narrowed down, and sequenced these products to determine
the exact location where a break had been capped by the telomere.
Aim 4. I compared break region distribution for both FRA3B and FRA7H with control nonbreak region data with respect to potential secondary-structure forming regions and potential
origins.
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Chapter 2
Materials and Methods
2.1 Description of YACs Containing Fragile Sites FRA3B and FRA7H
My study involved the use of two yeast strains carrying YACs containing human
common fragile site DNA. YAC 850a6 carries 1.3 Mb of human DNA, including a 632 kb
segment of FHIT, containing the most fragile regions of FRA3B along with regions of nonfragile DNA flanking the fragile site (Figure 7). 850a6 was created as part of the CEPH YAC
collection library (Dausset et al., 1992).	
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YAC yWSS11 carries and insert of 730 kb of human DNA and was created as part of
the Washington University YAC collection library (Brownstein et al., 1989; Burke et al.,
1987). The insert appears to contain segments of human DNA from more than one genomic
location. It includes a 288 kb segment of chromosome 7, which contains the approximately
161 kb FRA7H common fragile site (Hellman et al., 2000) along with regions of non-fragile
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DNA flanking the fragile site (Figure 8). The 288 kb segment of analyzable DNA is located
on the centromere-distal portion of the human DNA insert (Figure 8).
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2.2 Genetic Modification of YAC 850a6 and yWSS11
YAC modification was conducted in order to properly identify broken YACs through
phenotypic analysis. YACs 850a6 and yWSS11 were originally created by inserting human
DNA into the pYAC4 vector (Brownstein et al., 1989; Burke et al., 1987; Dausset et al.,
1992). The YAC vector contained two genetic markers, TRP1 and URA3. The TRP1 genetic
marker is located centromere-distal to the yeast origin on the left arm of the YAC, and the
URA3 genetic marker is located centromere-distal to the human insert on the right arm of the
YAC (Figure 9). These two genetic markers are useful in identifying broken YACs. The
TRP1 gene codes for an enzyme involved in the biosynthesis pathway for tryptophan. Yeast
strains with TRP1 can grow on selective media lacking tryptophan. URA3 codes for an
enzyme involved in the biosynthesis of uracil. Yeast strains with URA3 can grow on
selective media lacking uracil. The Ura3p enzyme also has the ability to bind to 5fluoroorotic acid (5-FOA), which will result in a conversion of 5-FOA to a toxic product.
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Therefore, cells that contain the URA3 gene will die on media containing 5-FOA. Cells with
intact YACs have the phenotype Trp+, Ura+, 5-FOAS. Cells with broken YACs have the
phenotype Trp+, Ura-, 5-FOAR. However, cells with a mutation in URA3 also have the
phenotype Trp+, Ura-, 5-FOAR. Therefore Rajula (2011) previously modified these YACs by
adding the HPH gene centromere-distal to the URA3 gene. This drug-resistant gene marker
gives cellular resistance to the drug hygromycin. This previous work allowed proper
identification of broken YACs when plating on selective media. Cells with a mutation in
URA3 have phenotype Trp+, Ura-, 5-FOAR, HygR and cells with a broken YAC have
phenotype Trp+, Ura-, 5-FOAR, HygS. The experimental YAC structure is depicted in Figure
9.

Figure 9. YAC model used in experimental procedure to identify break within the human
insert. TRP1, URA3 and HPH genetic markers were used to identify broken YACs on
selective media. YAC breaks result in tryptophan phototrophs, uracil auxotrophs, 5-FOA
resistance and hygromycin sensitivity.
2.3 Genetic Modification of Host Yeast Strains Carrying FRA3B and FRA7H YACs
Modification of the host strains carrying the YACs was necessary for two reasons: (1)
to be able to induce replication stress in the cells and (2) to prevent DNA repair processes
from obscuring YAC break locations. Modification of the host strain carrying FRA7H will be
documented here; modification of the host strain carrying FRA3B proceeded similarly. A
flow chart of the strain modification process is shown in Figure 11, and complete genotypes
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for all strains are reported in Table 1. In strain yWSS11, the mutant ade2 gene was replaced
with the wild-type ADE2 gene, resulting in strain Y134 (Rajula, 2011). This process was
completed through phenotypic selection of a spontaneous reversion from the ade2 gene to the
wild-type ADE2 gene. The wild-type ADE2 gene is necessary because the ade2 mutation
results in a buildup of a red precursor that causes a red cellular phenotype and causes
problems with cell growth (Dorfman, 1969). The spontaneous reversion results in a white
cellular phenotype with robust growth. The strain was then transformed using standard
protocols to insert the HPH resistance gene marker on the YAC resulting strain Y205, which
has a completely intact FRA7H YAC including the TRP1, URA3 and HPH resistance gene
markers (refer to Figure 9)(Rajula, 2011). I began strain modification at this point with
Y205. The next step of strain construction involved modification of the wild-type PIF1 gene
to the mutated pif1-m2 gene. The pif1-m2 mutation increases the frequency of telomere
addition at the end of double-stranded chromosomal breaks (Snow et al., 2007). This
increased telomere addition allows identification of break locations as close to the break site
as possible. I modified the PIF1 gene with the pif1-m2 gene through the mating of haploid
Y205 (carrying the YAC, PIF1) with haploid WS45 (no YAC, pif1-m2). The diploid was
sporulated by standard techniques (Guthrie and Fink, 1991), and haploids were obtained
through tetrad dissection microscopy. I identified pif1-m2 mutant haploids from tetrad
dissection by polymerase chain reaction (PCR), restriction enzyme digest, and gel
electrophoresis. The gene locus was amplified using forward primer 5’
CGTTCCAGGATAAAGGACTG and reverse primer 5’ CCCAAATCCATCGAAAGG.
The PCR product was then digested with Xho1, which does not cut a product of a wild-type
PIF1 gene but has one cut site in the mutant pif1-m2 gene. Two bands, one at 255 bp and the
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other 552 bp, allowed identification of pif1-m2 mutant haploids. The next step in stain
modification was to replace the native POL1 gene promoter with the galactose-inducible
GAL1/10 promoter. Yeast are insensitive to aphidicolin treatment (Cooley and Mishra, 2000)
(a method to induce replication stress in human cells) due to the drug’s inability to cross the
cell wall. This modification of POL1 permits an alternate form of replication stress (Lemoine
et al., 2005). The POL1 gene encodes for the catalytic subunit for yeast DNA polymerase α,
the primase that initiates DNA replication by adding the primer (Pollok et al., 2003). The
levels of Pol1p produced are now directly linked to the amount of galactose present on the
growth media. In low galactose media (0.005%), Pol1p transcription is approximately 10%
of normal levels (Lemoine et al., 2005). Low amounts of Pol1p available in the cells create
DNA replication stress and induce fragile site instability. Under levels of high galactose
media (0.05%), Pol1p transcription is approximately 300% of normal levels (Figure 10).
This increase in Pol1p, along with the fact that the promoter is active at all times when placed
on media containing galactose, results in a slight increase in fragile site instability (Lemoine
et al., 2005). This increase in instability could be attributed to the fact that only one subunit
of the polymerase activity is being overproduced. This has the potential to cause instability
when single subunits try to perform without the additional subunits. Even though high
galactose media creates this slight increase in instability, DNA replication is relatively
normal compared to low levels of galactose resulting in DNA replication stress.
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Figure 10. Inducing replication stress in experimental yeast strains. (A) Gal1/10 promoter
is fused to POL1 gene. Promoter is turned on when cells are grown on media containing
galactose. The POL1 gene encodes an enzymatic subunit of DNA polymerase α, the
primase that initiates DNA replication. (B) Under levels of high galactose, 300% of
normal Pol1p production is observed. Under low levels of galactose, 10% of normal
Pol1p production is observed, resulting in DNA replication stress (Lemoine et al. 2005).
My modification of the yeast strain to obtain the GAL-POL1 construct took place
during the same mating of Y205 (POL1) with WS45 (GAL-POL1), followed by sporulation
and tetrad dissection. The GAL1/10 construct also contains the drug resistance gene marker
KAN, which makes cells resistant to G418 (Lemoine et al., 2005). I selected haploids
containing the GAL-POL1 modification by identifying colonies that grew on selective media
containing the drug G418. The tetrad dissection of the cross between Y205 and WS45
resulted in a new haploid strain that contained an intact YAC with all genetic markers (TRP1,
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URA3 and HPH), the GAL-POL1 construct used for creating DNA replication stress, and the
pif1-m2 mutation to increase the frequency of telomere addition at break sites. This new
yeast strain was named Y313.
The yeast stain was modified to reduce the ability for the DNA to be repaired by
homologous recombination. Homologous recombination involves resection of DNA at break
sites to expose single-stranded regions that can invade areas of homology for repair. This
resection and repair processes can obscure initial break location sites. Two genes, EXO1 and
SGS1, resect DNA at break sites. The EXO1 gene codes for exonuclease 1 that possesses a
5’ to 3’ DNA resection ability. The SGS1 gene encodes Sgs1p, which is a RecQ helicase
responsible for unwinding secondary structures. Sgs1p also binds with Dna2p (an
exonuclease) to facilitate 5’ to 3’ resection of DNA (Chung et al., 2010). Knocking out both
EXO1 and SGS1 reduces the cell’s ability to resect DNA at double-stranded breaks. This
reduces the amount of DNA lost from the site of breakage prior to telomere addition or other
forms of repair. To knock out EXO1 and SGS1 in yeast strain Y313, I mated it with
AMC316. AMC316 was made by Rajula (2011) and contains an exo1Δ complete knockout
(created though a standard two-step transformation (Storici et al., 2001)) and sgs1 knocked
out with the drug resistance marker NAT (created though standard transformation techniques;
Kawai et al., 2010). I sporulated the diploid by standard techniques (Guthrie and Fink, 1991)
and again obtained haploids through tetrad dissection microscopy. Identification of
sgs1::NAT was determined through selective media containing the drug nourseothricin. The
exo1Δ was identified by polymerase chain reaction (PCR) and gel electrophoresis. This gene
locus was amplified by forward primer 5’ CTTACTCCAACCGTACCC and reverse primer
5’ GCTATGTTGGGTGGAACT with an expected wild type EXO1 length of 462 bp.
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Haploids with the desired genetic changes were selected, creating strain Y408. Y408 is the
FRA7H YAC working strain with all necessary modifications for experimental analysis
(Figure 11, Table 1).

Figure 11. Flow chart depicting the modifications to the host strain carrying the FRA7H
YAC used for experimental analysis. Boxes represent strains with relevant genetic
characterizations. Vertical arrows represent procedures to obtain correct modification in
the box below. Y408 contains all the necessary genetic strain modifications for
experimental use.
Genetic modification of the host strain containing the FRA3B YAC 850a6 was
completed by Rajula (2011) and other members of the Casper lab (Figure 12, Table 2). The
modifications to both the YAC and the host strain follow the similar steps and procedures as
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the FRA7H strain creation. Selection media used for verifying genetic modifications are
reported in Table 3.

Figure 12. Flow chart depicting the modifications to the host strain carrying the
FRA3B YAC used for experimental analysis. Boxes represent strains with relevant
genetic characterizations. Vertical arrows represent procedures to obtain correct
modification in the box below. AMC319 contains all the necessary genetic strain
modifications for experimental use. The DNL4 gene, which plays a role in nonhomologous end joining, was originally taken out, but then reinserted into host strain.
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Table	
  1.	
  	
  Strain	
  construction	
  and	
  complete	
  genotypes	
  for	
  all	
  strains	
  in	
  the	
  creation	
  of	
  
Y408,	
  used	
  to	
  map	
  breaks	
  along	
  the	
  FRA7H	
  insert.	
  

Strain
Name
yWSS11*

Relevant Genotype

Reference or Construction details•••

MATa trp1/TRP1
ura3-52/URA3 ψ+

(Brownstein et al., 1989; Burke et al., 1987)

Y134*

MATa trp1/TRP1
ura3-52/URA3
ADE2 ψ+
MATa trp1/TRP1
ura3-52/URA3
ADE2
YAC2970::HPH ψ+

Created by spontaneous reversion from ade2-1 to
ADE2. Streaked out strain provided white colony
representing wild-type ADE2.
Created by transformation of Y27 with PCR product
targeted to insert HPH on the YAC at base 2970.
Primer P17
(5’ TGATCGTGCTCCTGTCGTTGAGGACCCGCT
AGGCTGGCGGGGTTGCCTTcgtacgctgcaggtcgac)
and P18
(5’ CAGTCGCTTCACGTTCGCTCGCGTATCGGT
GATTCATTCTGCTAACCAGTatcgatgaattcgagctcg)
were used to amplify HPH gene from plasmid pAG32
(Goldstein and McCusker, 1999)
Gift from the laboratory of T. Petes, Duke University

Y205*

WS45**
EAS18**
Y44**

	
  

MATα rad52::NAT
dnl4::HPH pif1-m2
KanMX:GAL-POL1
MATa DNL4,
RAD52
MATa exo1Δ
sgs1::NAT DNL4
RAD52

Gift from the laboratory of T. Petes, Duke University
Created by two-step transformation (Storici et al.,
2001) of EAS18 to delete EXO1. For the first step (to
replace exo1 with pCORE). Primers P38
(5’TTTTCATTTGAAAAATATACCTCCGATATGA
AACGTGCAGTACTTAACTTtccttaccattaagttgatc)
and P39
(5’ TTGCTCCTTCAGGTATATCTATATGCTCTC
ATAGAATTATATTTGATATTgagctcgttttcgacactg
g) were used to amplify pCORE from pCORE
plasmid (Storici et al., 2001). This product was
transformed into EAS18.
For the second step (to remove pCORE), cells were
next transformed with oligonucleotides P40
(5’ AAAAATATACCTCCGATATGAAACGTGCA
GTACTTAACTTAATATACAAATATAATTCTAT
GAGAGCATATAGATATACCT)
and P41
(5’ AGGTATATCTATATGCTCTCATAGAATTAT
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AMC316**

Y313

Y408

Y446-Y455,
Y457, Y459,
Y461-Y478

MATα rad52::NAT
DNL4 RAD52
pif1-m2
KanMX:GALPOL1
MATa DNL4
RAD52 pif1-m2
KanMX:GALPOL1
YAC2970::HPH ψ+
MATα pif1-m2
KanMX:GALPOL1
YAC2970::HPH
exo1Δ sgs1::NAT
ψ+
MATα pif1-m2
KanMX:GALPOL1
YAC2970::HPH
exo1Δ sgs1::NAT
ψ+

ATTTGATATTAGTTAAGTACTGCACGTTTCAT
ATCGGAGGTATATTTTT)
Then, the new strain was transformed with a PCR
product targeted to replace sgs1 with NAT. Primer P23
(5’TATTGATAAACGTTACGGAAGTATTTAATG
TACATATGTAGGATAGTATTcgtacgctgcaggtcgac)
and P24
(5’ATTGATATCAGCACTAGATTCTATACCCG
AGCCCCAAAACTTTGCGCCTAGTatcgatgaattcga
gctcg) were used to amplify the NAT gene from
plasmid pAG25 (Goldstein and McCusker, 1999)
Spore colony from WS45 x Y44 cross

Spore colony from Y205 x WS45 cross

Spore colony from Y313 x AMC316 cross

Strains containing a broken FRA7H YAC. Loss of
URA and HPH genes in the YAC.

Strains with *are isogenic with strain AB1380 (MATa ade2-1 can1-100 lys2-1 trp1 ura3
his5 ψ+) (Albertsen et al., 1990; Burke et al., 1992; Dausset et al., 1992) except for
changes introduced by transformation as noted under “Relevant Genotype”.
Strains with ** are isogenic with MS71, a LEU2 derivative of AMY125 (a _ade5-1 leu2-3
trp1-289 ura3-52 his7-2) (Kokoska et al., 2000) except for changes introduced by
transformation as noted under “Relevant Genotype”.
*** Primers to amplify PCR products for transformation are shown with the targeting
region of homology in capital letters and the region for amplification of the desired gene
in lowercase letters.
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2.	
  	
  Strain	
  construction	
  and	
  complete	
  genotypes	
  for	
  all	
  strains	
  in	
  the	
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  of	
  
AMC319,	
  used	
  to	
  map	
  breaks	
  along	
  the	
  FRA3B	
  insert.	
  

Strain
Name
850A6*

Relevant Genotype

Reference or Construction details•••

MATα trp1/TRP1
ura3-52/URA3 ψ+

(Wilke et al., 1994)

Y25*

MATα trp1/TRP1
ura3-52/URA3
ADE2 ψ+

Y27*

Y30*

WS45**
EAS18**
Y42**
Y43**

	
  

Created by transformation of 850a6 with PCR product
targeted to replace ade 2-1 with ADE 2; Primers
AMC247 (5’ACCGTCCCAGGAGCTACCAC) and
AMC249 (5’CGCTCGTTAAAGGTATTAATTGT)
were used to amplify ADE2 gene from yeast genomic
DNA
MATα trp1/TRP1
Created by transformation of Y25 with PCR product
ura3-52/URA3
targeted to replace dnl4 with NAT. Primer P23
ADE2 dnl4::NAT ψ+ (5’TATTGATAAACGTTACGGAAGTATTTAATG
TACATATGTAGGATAGTATTcgtacgctgcaggtcgac)
and P24
(5’ATTGATATCAGCACTAGATTCTATACCCG
AGCCCCAAAACTTTGCGCCTAGTatcgatgaattcga
gctcg) were used to amplify the NAT gene from
plasmid pAG25 (Goldstein and McCusker, 1999)
MATα trp1/TRP1
Created by transformation of Y27 with PCR product
ura3-52/URA3
targeted to insert HPH on the YAC at base 2970.
ADE2 dnl4::NAT
Primer P17
YAC2970::HPH ψ+ (5’ TGATCGTGCTCCTGTCGTTGAGGACCCGCT
AGGCTGGCGGGGTTGCCTTcgtacgctgcaggtcgac)
and P18
(5’ CAGTCGCTTCACGTTCGCTCGCGTATCGGT
GATTCATTCTGCTAACCAGTatcgatgaattcgagctcg)
were used to amplify HPH gene from plasmid pAG32
(Goldstein and McCusker, 1999)
MATα rad52::NAT
Gift from the laboratory of T. Petes, Duke University
dnl4::HPH pif1-m2
KanMX:GAL-POL1
MATa DNL4,
Gift from the laboratory of T. Petes, Duke University
RAD52
MATa rad52::NAT
Spore colony from WS45 x EAS18 cross
DNL4 pif1-m2
KanMX:GALPOL1
MATa exo1Δ DNL4 Created by two-step transformation (Storici et al.,
sgs1::NAT
2001) of EAS18 to delete EXO1. For the first step (to
replace exo1 with pCORE). Primers P38
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Y74

AMC319

Y337, Y339,
Y340, Y344,
Y346, Y348,
Y350, Y351,
Y353-Y357,
Y363, Y387,
Y389, Y392,
Y397-Y404,
Y441, Y442,
Y444, Y445

	
  

MATα dnl4:NAT
pif1-m2
KanMX:GALPOL1
YAC2970::HPH ψ+
MATa pif1-m2
KanMX:GALPOL1
YAC2970::HPH
exo1Δ sgs1::NAT
ψ+
MATa pif1-m2
KanMX:GALPOL1
YAC2970::HPH
exo1Δ sgs1::NAT
ψ+

(5’TTTTCATTTGAAAAATATACCTCCGATATGA
AACGTGCAGTACTTAACTTtccttaccattaagttgatc)
and P39
(5’ TTGCTCCTTCAGGTATATCTATATGCTCTC
ATAGAATTATATTTGATATTgagctcgttttcgacactg
g) were used to amplify pCORE from pCORE
plasmid (Storici et al., 2001). This product was
transformed into EAS18.
For the second step (to remove pCORE), cells were
next transformed with oligonucleotides P40
(5’ AAAAATATACCTCCGATATGAAACGTGCA
GTACTTAACTTAATATACAAATATAATTCTAT
GAGAGCATATAGATATACCT)
and P41
(5’ AGGTATATCTATATGCTCTCATAGAATTAT
ATTTGATATTAGTTAAGTACTGCACGTTTCAT
ATCGGAGGTATATTTTT)
Then the new strain was transformed with a PCR
product targeted to replace sgs1 with NAT. Primer P23
(5’TATTGATAAACGTTACGGAAGTATTTAATG
TACATATGTAGGATAGTATTcgtacgctgcaggtcgac)
and P24
(5’ATTGATATCAGCACTAGATTCTATACCCG
AGCCCCAAAACTTTGCGCCTAGTatcgatgaattcga
gctcg) were used to amplify the NAT gene from
plasmid pAG25 (Goldstein and McCusker, 1999)
Spore colony from Y42 x Y30 cross

Spore colony from Y43 x Y74 cross

Strains with a broken FRA3B YAC. Loss of URA and
HPH genes in the YAC.
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Strains with *are isogenic with strain AB1380 (MATa ade2-1 can1-100 lys2-1 trp1 ura3
his5 ψ+) (Albertsen et al., 1990; Burke et al., 1992; Dausset et al., 1992) except for
changes introduced by transformation as noted under “Relevant Genotype”.
Strains with ** are isogenic with MS71, a LEU2 derivative of AMY125 (a _ade5-1 leu2-3
trp1-289 ura3-52 his7-2) (Kokoska et al., 2000) except for changes introduced by
transformation as noted under “Relevant Genotype”.
*** Primers to amplify PCR products for transformation are shown with the targeting
region of homology in capital letters and the region for amplification of the desired gene
in lowercase letters.
	
  	
  
2.4 Mapping the Extent of Human DNA Present in the Initial YACs
Previous research identified the extent of the FRA3B YAC insert within the strain
850a6 (Durkin et al., 2008). I used a control portion of the FRA3B YAC from the beginning
of the FHIT intron 3 (61,016,766 bp along the left arm of chromosome 3) to midway into
FHIT intron 5 (60,384,099 bp along the left arm of chromosome 3). The reasoning for this
experimental length was due to the fact that Rajula (2011) only found breaks occurring
within this region. PCR was used to test if AMC 319 contained a complete YAC insert from
chr3: 61,016,766-60,384,099. 16 original primer sets (Table 4, gray background) were used
to develop a map of the YAC within AMC319. The PCR was carried in 10 µl reactions
containing 4 µl of isolated DNA. DNA was isolated by a boil/freeze method in which a
colony of cells was put into 30 µl of sterile distilled water, boiled at 100oC for 6 minutes and
then immediately transferred to -80o C for 10 minutes. Cellular debris was spun down, and
then DNA was taken for reaction from supernatant. The reaction also consisted of 0.4 µM
final concentration of each primer, and 5U/ µl GoTaq Green master mix (Promega
Corporation, Madison, WI). The PCR cycling conditions were 94o C for 2 min, followed by
35 cycles at 94o C for 30 sec, 55o C for 30 sec, and 72o C for 1 min, with a final extension at
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72o C for 7 min. Initial primer sets were used to identify the extent of the FRA3B insert
within AMC 319 (Figure 13; Table 4, gray background).

Figure 13. Diagram of distribution of 17 initial primer sets used to identify extent of
FRA3B insert within AMC319.
Numbering of bp within the insert decreases as primer set increases because previous
research in the Casper Lab had identified that the human DNA segment in the YAC is
inserted in an orientation opposite that of the orientation in the human genome (Rajula,
2011)(Table 4).
The extent of the FRA7H fragile site within yWSS11 had not previously been
identified; therefore I first needed to determine how much of chromosome 7 was present
within the insert in strain Y408. Hellman et al. (2000) described FRA7H as a 161 kb region
on the right arm of chromosome 7. I created 18 primer sets (Table 5, gray background) using
the Primer 3 Program (http://frodo.wi.mit.edu/) to evaluate the human DNA present in the
YAC in strain Y408. I created primer sets within as well as along side of the known 161 kb
region describe by Hellman et al. (2000). Primer sets were spaced approximately 20 kb apart.
The PCR was carried out in 10 µl reactions containing 4 µl of isolated DNA (again from
boil/freeze isolation method). The reaction also consisted of 0.4 µM final concentration of
each primer, and 5U/ µl GoTaq Green master mix (Promega Corporation, Madison, WI). The

	
  

38	
  

PCR cycling conditions were 94o C for 2 min, followed by 35 cycles at 94o C for 30 sec, 55o
C for 30 sec, and 72o C for 1 min, with a final extension at 72o C for 7 min. Initial primer sets
were used to identify the extent of the FRA7H insert within Y408 (Figure 14; Table 5, gray
background).

	
  
Figure 14. Diagram of distribution of 18 initial primer sets used to identify extent of
FRA7H insert within Y408.
	
  
Numbering of bp within the FRA7H insert decreases as primer set increases because
I identified that the human DNA segment in the YAC is inserted in an orientation opposite
that of the orientation in the human genome (Results section 3.2).
2.5 Experimental Design to Induce Breaks in Working YAC strains.
A. Growth Conditions and Use of Media.
All media used for growth and selection of broken YAC colonies was standard
(Guthrie and Fink, 1991), except for the high and low galactose concentrations added and the
use of raffinose instead of dextrose as the yeast carbon source. Dextrose (D-glucose) is a
preferred yeast carbon source in experimental procedures. However, dextrose represses the
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GAL1/10 promoter fused to the POL1 gene independently of the amount of galactose present
on the media. Raffinose does not affect the GAL1/10 promoter thereby allowing control of
Pol1p to be dependent only on the amount of galactose present on the media (Johnston,
1987). The amount of galactose added to growth media was either at high galactose
concentrations (0.05% galactose) or low galactose concentrations (0.005%) (Lemoine et al.,
2005). This adjustment of galactose in the media allows for induction of replication stress
during the experimental procedure. All yeast strains were grown at 30o C.
B. Inducing Breaks Within YACs
To induce fragile site breaks in the YACs with FRA3B and FRA7H, the experimental
yeast strains with these YACs were first plated onto complete medium that contained high
levels of galactose (0.05% galactose and 3% raffinose, Table 3). Growth on complete
medium overnight ensured healthy growth before inducing replication stress. Strains were
then streaked for single colonies onto complete medium containing high galactose and the
drug hygromycin. Colonies that grow on this medium must contain the drug resistance
marker HPH located on the distal end of the right arm of the YAC (Figure 7), and therefore
these cells are likely to contain an intact YAC. 100 single colonies containing intact YACs
were then individually patched onto complete medium containing low levels of galactose
(0.005% galactose, 3% raffinose, Table 3) and incubated at 30o C overnight. This process
induced replication stress in the yeast cells due to low levels of Pol1p. This stress was
expected to induce breaks within fragile site region in the inserted the human on the YAC.
Patches were then replica plated by velvet transfer onto minimal medium containing high
levels of galactose, 5-FOA and lacking tryptophan (Table 3) and incubated for two nights at
30o C. Cells that still contain URA3 gene on the right arm of the YAC, centromere distal to
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the human DNA insert, will die on this selective medium. Also, cells that are lacking the
YAC entirely will not grow on this medium because they lack the TRP1 gene. Therefore,
cells that grow must contain the left arm of the YAC including the TRP1 gene and have
either lost or mutated the URA3 gene. A single colony from each patch growing on this
medium was isolated by streaking onto complete medium containing high levels of galactose.
A single colony was taken from each streak and patched onto complete medium containing
high galactose and incubated at 30o C overnight. Patches were replica plated by velvet
transfer onto minimal medium containing high levels of galactose, 5-FOA and lacking
tryptophan as well as replica plated to rich medium containing hygromycin (Table 3).
Patches that were TRP1 prototrophs, URA3 auxotrophs, 5-FOA resistant, and hygromycin
sensitive likely contain a break in the inserted human DNA on the YAC and were collected
for further analysis (Figure 15).

Figure 15. Visual representation of YAC breakage during replication stress. (A) Intact
YAC before experimental induction of replication stress. (B) Broken YAC after induced
replication stress by growth on low galactose medium. Break is expected to occur within
human DNA insert. (C) Broken YAC with addition of telomere cap to maintain DNA
stability.
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Table 3. Names and formulations of media used in experimental procedures of this study.

Media Name

Ingredients in 1 Liter of Media

YPR Liquid Media

10 g Yeast Extract, 20 g Peptone, 30 g Raffinose, 1 L H20
10 g Yeast Extract, 20 g Peptone, 30 g Raffinose, 1 L
H20, 30 g Agar, 2.5 mL 20% Galactose
10 g Yeast Extract, 20 g Peptone, 30 g Raffinose, 1 L
H20, 30 g Agar, 0.250 mL 20% Galactose
10 g Yeast Extract, 20 g Peptone, 30 g Raffinose, 1 L
H20, 30 g Agar, 200 mg Hygromycin B, 2.5 mL 20%
Galactose
10 g Yeast Extract, 20 g Peptone, 30 g Raffinose, 1 L
H20, 30 g Agar, 100 mg Nourseothricin, 2.5 mL 20%
Galactose
10 g Yeast Extract, 20 g Peptone, 30 g Raffinose, 1 L
H20, 30 g Agar, 200 mg G418 Sulfate, 2.5 mL 20%
Galactose
1.7 g Yeast Nitrogen Base without Amino Acids and
without Ammonium Sulfate, 5 g Ammonium Sulfate, 30
g Raffinose, 1 L H20, 30 g Agar , 1.4 g Amino Acids (tryptophan)
1.7 g Yeast Nitrogen Base without Amino Acids and
without Ammonium Sulfate, 5 g Ammonium Sulfate, 30
g Raffinose, 1 L H20, 30 g Agar, 1.4 g Amino Acids (uracil)
10 g Potassium Acetate, 1 g Yeast Extract, 0.5 g
Raffinose, 1 L H20, 30 g Agar, 1 mL 0.5% Adenine
Solution, 2.5 mL 20% Galactose
10 g Tryptone, 5 g Yeast Extract, 10 g NaCl, 30 g Agar, 1
L H20, ph 7.5, 100 mg AMP, 40 mg Xgal (per plate)
2 g Yeast Nitrogen Base without amino acids and without
ammonium sulfate, 5 g Ammonium Sulfate, 30 g
Raffinose, 40 mg Uracil, 1.4 g Amino Acids (tryptophan), 1 g 5-FOA, 1 L H20, 30 g Agar, 2.5 mL 20%
Galactose

YPR + HG Agar Media
YPR + LG Agar Media
YPR + HG Agar Media +
Hygromycin
YPR + HG Agar Media +
Nourseothricin
YPR + HG Agar Media +
Geneticin (G418) Sulfate
SR Agar Media –Tryptophan

SR Agar Media -Uracil

SPO + HG Agar Media
LB + Ampicillin + Xgal

SR-TRP+HG+5-FOA Agar
Media
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2.6 Initial Primer Set Polymerase Chain Reaction (PCR) For Investigation of Broken
YACs
Cells that contain a break in the YAC as identified by phenotypic analysis (section
2.3) were initially tested by PCR with primer sets in the YAC insert. Strains containing
intact YAC were used as controls for the PCR reactions (AMC319 for FRA3B YAC and
Y408 for FRA7H YAC). For strains containing a broken FRA3B YAC, primer sets for initial
PCR testing included FRA3B Primer set 1 and FRA3B Primer set 16 (Table 4). For strains
containing a broken FRA7H YAC, primer sets for initial PCR testing included FRA7H
Primer set 1 and FRA7H primer set 16 (Table 5). The PCR was carried out in 10 µl reactions
containing 4 µl of isolated DNA. The reaction also consisted of 0.4 µM final concentration of
each primer, and 5U/ µl GoTaq Green master mix (Promega Corporation, Madison, WI). The
PCR cycling conditions were 94o C for 2 min, followed by 35 cycles at 94o C for 30 sec, 55o
C for 30 sec, and 72o C for 1 min, with a final extension at 72o C for 7 min. Broken YACs
that had no product at both initial primer sets, or that a positive product at both initial primer
sets, were not pursued. 30 strains from each YAC with a product at the centromere-proximal
primer set and no product at the centromere-distal primer set were chosen for further
analysis.
2.7 Narrowing of YAC Break Locations
Total yeast genomic DNA from cells containing the intact YACs (AMC319 and
Y408) as well as from each set of 30 broken YACs chosen for further analysis was extracted
by standard protocol (Lõoke et al., 2011). This harvested DNA was used for further PCR
analysis to narrow break locations using the same 16 primer sets used to identify intact
FRA3B in AMC319 (in the case of 30 FRA3B broken YACs; Table 4, gray background) or
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16 primer sets used to identify extent of FRA7H in Y408 (in the case of 30 FRA7H broken
YACs; Table 5, gray background). PCR reactions were carried in 10 µl reactions containing
100 ng of genomically harvested DNA, 0.4 µM final concentration of each primer, and 5U/
µl GoTaq Green master mix (Promega Corporation, Madison, WI). PCR cycling conditions
were the same as initial testing of broken YACs. Each YAC was assigned a break location
based on this initial set of PCR primers.
I then created new additional primer sets to further narrow the break locations using
the Primer 3 program (http://frodo.wi.mit.edu/) and the UCSC genome browser
(http://genome.ucsc.edu/). All primer sets used in narrowing of FRA3B break locations are
reported in Table 4. All primer sets used in narrowing of FRA7H break locations are
reported in Table 5. The break location in each strain was narrowed by standard PCR to a
break region smaller than 6 kb. Based on this PCR mapping, a Critical Break Area (CBA)
was determined for each broken YAC. The CBA is the distance between the 5’ end of the
last reverse primer that was positive in the YAC insert to the 5’ end of the first reverse primer
that was negative in the YAC insert plus 4 kb. The CBA is the region within which the break
most likely occurred, and CBA determination is discussed in detail in the results section.
2.8 Agarose Gel Electrophoresis
All products of standard PCR reactions were separated by agarose gel electrophoresis
for visual analysis. Agarose gels contained 0.8% agarose in 0.5X TBE. PCR products were
identified by GelRed staining (Biotium Inc, Hayward CA). Gel running conditions were at
96 volts for between 30 min to 1 hr.
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Table 4. Primers used to amplify regions of FRA3B within YAC.
Primer Set
SET 1
SET 1.0.1
SET 1.1
SET 1.15
SET 1.2
SET 1.1.1
SET 2
SET 2.0.0.1
SET 2.0.1
SET 2.1
SET 3
SET 4
SET 5
SET 6
SET 7
SET 8
SET 8.0.1
SET 8.0.2
SET 8.1
SET 8.1.0.1
SET 8.1.1
SET 9
SET 10
SET 11
SET 11A
SET 11A.1
SET 11A.2
SET 11A.3
SET 11B
SET 11B.1
SET 11B.2
SET 11B.3
SET 11C
SET 11C.1
SET 11C.1.1
SET 11C.1.2
SET 11C.2
SET 11C.3
SET 11C.4
SET 11D
SET 11E
SET 11F
SET 12
SET 12.1

	
  

Forward Primer
aataacttttgatcgggttgaag
gcccttaggcatggtgtctg
cacccattgctgtgaaattg
gggtacgcccttacagatgg
gcgatcttcccactttggtc
acagggtagcccaagaggtg
aaggccttgtggattgtgac
tttcttgcatgagggtcagc
tggaattgggtggtatttgg
tgtgcattccagcatccttc
cttcagccttgcttctgtcc
tcatggtcttctcagcatcttattc
gagaatttcctcatgattttcaaggt
tcatcccacctcaaatgtca
ggggagaccaatcctttgtt
tgatgttcagcaaggggata
agccttgggttaagggaatg
tgactgcccaagattgaacc
tgcatgaggtagggcatgtg
cctgtgtaaccaccgcttgg
gaagtgggcaggcagaacac
aaataatagatgttggtggggatgt
ctgggagcataaataccaaactgtg
gggactttgccttgcttcttg
ctttctttagctgtggtggtgaata
cccggctgattgtacctttc
tgccttgcctcatgtctcac
ctctcacccagccttgaacg
tctccccagccaacattaac
cactgccacctctgcttacc
tgacagtgattccagtgcag
tcgtcctggtgtcttcaaac
aaagaggaaaatgctggtatcaaag
gctgactgatcatggtggtg
tatcagagcccttgggtgac
agtatgcctgcactgactgg
aacaagctcttgggtgatgc
ctaccacctggctgcttagg
tctgcactgggagaacacac
tctgtatatagacggatcaccaga
tgagatgaagtcttgctttgttacc
gccaaagaaccagaagttcattatt
ggaatttgctttctttaaggtggta
ccagggcatacctgagtttg

Reverse Primer
ttcaaggatttatttgcactaacca
gagggccacagctggagaac
atgcatggcttattcccaga
ttccctccaaagcactcacc
ttgcagcaacatggaactgg
accttcccaggacccaaatc
ctcgggagagaacattgcat
aacttgactgggccatgagg
attggaggtccaggctttgg
tgggctgaggcctttagatg
attttgcgccttgaatttg
gagaattgatggtttgtgttttgtc
agaaacatttgcctttcctaagcta
gcacccacccctagacacta
aatggcactggaaagtggag
tcaggtacaggggaaatgtca
gcctcttgcaccaaatagcc
ttggctatgaagccatccag
ccaacgtctcccatctctgg
ttgcccaccttcattcatcc
tgtggttgcatccttgttgc
attggaaattgtgctgctataaaca
tgcagactgaaccataacataacct
agaacagggctgctcaaatgtgc
cttagacaattccaggtgactcaaa
aatctgggacaatccgttcc
gttgggaacatcgtttgtgc
caacagcctgcaatgtggac
ccacaccctgtggtttcttt
cacatgaggtcaggtgttcg
ttccaaagcccagactatgc
ttcccaaagaggctaactcc
tttttaatgaattccctttcagctc
caacagcactgtcaaagacg
tcagtggtccttgagcattc
agcaagcatggagaaaccac
aaatgaagccagcaatccag
ttacagtgcctgggacacac
catctgcttgcttggttcac
tccaacactaacaagctagcagact
agaagtttggtgatgtttttgtgag
aagtgaagttggccaataatttctc
ctcagctatggtagtgaaaaggtca
actgagcagggttcatttcc

Size
639 bp
169 bp
151 bp
192 bp
235 bp
225 bp
227 bp
199 bp
342 bp
244 bp
343 bp
443 bp
319 bp
207 bp
167 bp
180 bp
184 bp
128 bp
178 bp
536 bp
153 bp
233 bp
363 bp
162 bp
901 bp
238 bp
170 bp
191 bp
188 bp
174 bp
144 bp
182 bp
535 bp
198 bp
234 bp
204 bp
203 bp
174 bp
237 bp
412 bp
892 bp
763 bp
493 bp
151 bp

Location on chr3:
61016127-61016766
60898635-60898803
60879994-60880144
60874842-60875033
60870259-60870493
60860770-60860994
60842170-60842396
60837633-60837831
60834214-60834555
60827622-60827865
60813166-60813508
60778585-60779017
60750667-60750985
60725097-60725303
60711731-60711897
60673942-60674121
60667292-60667475
60663506-60663633
60660467-60660644
60656718-60657253
60653799-60653951
60647221-60647453
60606504-60606866
60566649-60566810
60563626-60564526
60562243-60562480
60560698-60560867
60559237-60559427
60558353-60558540
60556840-60557013
60555772-60555915
60555101-60555282
60554473-60555007
60550594-60550791
60549831-60550064
60548862-60549065
60548194-60548396
60545988-60546162
60543344-60543580
60541506-60541918
60538934-60539825
60530299-60531061
60522300-60522792
60520497-60520647
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SET 12.1.1
SET 12.1.2
SET 12.2
SET 12A
SET 12B
SET 12C
SET 12D
SET 12E
SET 12F
SET 12G
SET 12H
SET 12I
SET 12K
SET 12J
SET 12L
SET 12M
SET 12N
SET 13
SET 13A
SET 13B
SET 13C
SET 13D
SET 13E
SET 13F
SET 13G
SET 13G.1
SET 13G.2
SET 13G.3
SET 13G.3.1
SET 13G.3.2
SET 13G.4
SET 13H
SET 13H.1
SET 13H.2
SET 13H.3
SET 13H.4
SET 13H.5
SET 13H.6
SET 13H.7
SET 13H.8
SET 13J
SET 13K
SET 13L
SET 13M
SET 13N
SET 13O
SET 13P

	
  

cctttgcttgcagaaagctc
agacaggatgtgccgaaatc
ttctgtggtgcaacgcttag
ttgtttctggagccgagact
gaaaagctgaggcacagacc
cgcggaataaacagctaaggc
accttttcggtagccctttg
gctcaagcaatctacctcag
ggggtggctggaaaagtaatgg
gccggagtgatcctgttaag
ttttcagccaccaatttatggtaa
cagcctactatcttgatccatctca
ccctttttgtctgttgctgt
cgaccatttctgtatagctc
ggaagcctggtctttatcgt
gctgttctagtttcccac
gctggaggccattgtctttagc
gctttgggtctgctccattg
taaaaacacacaatggaccagaact
gcaggtttggctctagggcc
ggttgggagaaatcagcatcc
gccactctggtgggtaaaag
gctgggaaggatagttgaca
gcacaactcagcaccatttgg
gagcaagaggtttaaaagagacacc
tgcctgaatatagggcttgg
ttgctgcacctattgacctg
ttacccaggattcactcagg
tgacctggcctttctctctg
atttggtttggctgtcttgc
catgcctcttgaccattgtg
tgtcttttactggatcccatctgta
cacttgtggcgtcagctcag
cagcaacaccttgagagcag
ttcttgcagagtgcatcacc
tgaactcccaaaggtcaaag
ggcaataacaagtgctggag
tgctctacgtcttgggtttc
agcttgcttgggaggctaag
ccttgaagaggtccttcacc
atcttgtgtgtacaaacccatctgt
ggccgtaagattgctgagct
tccctctctcccctgaaact
gttttcgtggcttaggacgt
agtttctttgaggcctgctg
ataccttgtgggcaacataattttt
gggataacagggagtcttgc

tagactagggcaggcaggag
ctcccatctgccatcaattc
agcacaaagcaaagggagtg
tcgtgggtatgtcaccttca
aagtggggctaatgggaaag
gctgaggttggtgcttctgggc
ccttttaggtctgccggtgttcc
gcgttaaaggcagagtggtc
tgaagggatcacaccctacc
tgaaatcagaggggcaatgg
tctacttgttaaatgaggaccgttg
aatcaccaacaaatgctaaaagaaa
atgccaggaaatgaggacagc
agggggtgaaaagtgttctg
tgaatggagcatctgctgag
aatgtgactcttggcgattcc
gctcaggggtacgagggtagg
atgtgtgtggtctgggttgg
tgatgatgttgctttcacactagaa
ccacttcctcaccatgcttc
ggtcggtacaggtagagttgctgc
aactggggatatccaacagc
cattccccactacccactcc
ggccccctaactaaggcagtc
caataagaacatctgcctgctttag
ggcctatgacagcagggtag
acatggaagaagctggaagc
cccaacgcaacagaatacac
agcaagacagaccaacatgc
cacagtggcaggagagaaag
atggttcagacgtgcctttc
tatgcatttcttagtgcctcttgc
gggacccaggtagtttgcag
gcatgtcccagagttgatcc
ccaagcggcaagataaagtc
ttccactgaaacatctgctg
atacctagcagcgagtttgc
ccctggcacagaacactttc
tgcccatctgctttctcaac
cccaaatccatccatgacag
tgcaacctacatgggaaaataacta
cccacaatccttcccaggagac
ggccaggcaccaggctagga
ctgcttgtaacgagccagtg
gaaaagcagcctgtggactc
ttttaacctcagccctaggagacta
attcccaggaagccactcac

154 bp
211 bp
245 bp
195 bp
201 bp
626 bp
192 bp
121 bp
159 bp
172 bp
607 bp
678 bp
193 bp
364 bp
169 bp
1058 bp
286 bp
126 bp
186 bp
782 bp
715 bp
861 bp
434 bp
204 bp
948 bp
158 bp
199 bp
227 bp
155 bp
206 bp
215 bp
499 bp
221 bp
165 bp
221 bp
103 bp
118 bp
253 bp
209 bp
162 bp
499 bp
572 bp
478 bp
474 bp
488 bp
509 bp
218 bp

60519699-60519852
60518821-60519031
60518133-60518377
60516067-60516261
60513478-60513678
60512216-60512841
60512071-60512262
60511503-60511623
60511132-60511290
60510716-60510887
60509714-60510320
60497842-60498519
60497522-60497714
60496704-60497067
60496190-60496358
60494901-60495958
60493271-60493556
60492393-60492518
60485944-60486129
60485099-60485880
60482871-60483585
60481347-60482207
60479940-60480373
60476633-60476836
60475348-60476295
60474313-60474470
60471239-60471437
60468092-60468318
60467017-60467171
60465874-60466079
60464850-60465064
60464201-60464699
60461296-60461516
60458764-60458928
60456456-60456676
60454749-60454851
60450623-60450741
60446775-60447028
60444413-60444622
60442468-60442629
60441408-60441907
60440543-60441114
60439186-60439663
60436539-60437012
60432850-60433286
60432277-60432785
60431356-60431573
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SET 13Q
SET 13R
SET 14
SET 14A
SET 14A.1
SET 14A.2
SET 14B
SET 14B.1
SET 14B.2
SET 14B.3
SET 14B.4
SET 14C
SET 14C.1
SET 14C.2
SET 14D
SET 14D.1
SET 14E
SET 14E.1
SET 14F
SET 14G
SET 14G.1
SET 14G.2
SET 14H
SET 14H.1
SET 14H.2
SET 14H.3
SET 14H.4
SET 14I
SET 14I.1
SET 14I.2
SET 14I.3
SET 14I.4
SET 14I.5
SET 14I.6
SET 14I.7
SET 14I.8
SET 14I.9
SET 14I.10
SET 14K
SET 14K.1
SET 14K.2
SET 14L
SET 14M
SET 14M.1
SET 15
SET 15A
SET 15B

	
  

aagccacatctgtggtgagg
gcattgccaagtcaatcctg
actccctgcattgacatggt
ggacaatgcgcctacctctg
aaagcagggttctgaagtgg
ttctgggtaccacggacatc
gcatgttctgggtggtcgtc
gtgtcatggcgggcatagag
tgtatggccacagacattacattc
ctttgcagggataaggatgg
agacgtgtgcaccattcttc
atgctaatggcctgctgctg
gaaggaggaaagcagggaag
tgtgaatcagaaccgcagtg
ctcctgtcaccaatgcttcc
atgcaggagaccacggatac
ttgagccttcgtccttcacc
gacccacaatgaaccagaac
ttccatcctcatcccaaccac
gagggaaggcagagggtacg
cagtagggagggaattcgtg
atccaggaagtctggctctg
atctttggcagtggtcttgg
tttgggcatgtttgtgtgtg
gggccaagtgatttaacctc
gcactgtttctcacgctctg
aaggcatgccagcttcaatc
gccctcacactgcctaagag
tttctgggtctcaccatctg
tcggccaaagctttattctc
tttgagtggtctgggaagag
ttatgagacgggcactgttg
ccttgcctgctttatctgtg
aagcctatgcctttgtcagc
ggtctcgctctcctgacctc
aaggccaaatcacataatgc
aactctgaggatggctctgg
ggtgacatcagcatcacctg
agaactgcccgagactgtgt
ggactatgaggaacgcaagc
acatcctccctgtcatttgc
ggggttaatgcttctccatc
ctagctttggcagaaatgcc
tggcaaaccaagttcctgtg
tgaaatctgtactctcctgttttgc
cgctttcctgcatatagcag
ggtggagtgtgtccaggttc

tctggctgaggagaaactgc
ctgagggctctgtcctgtcc
cttgctgctgtacctcttgc
tgttcatgctgcgttccatc
agggcttctactgtgctctg
gaggtctcacaacagccttc
tgcaccgtagtccagctcac
acatgtgggcaagactgctg
aaacagaccaacagaagctctagg
tcgtctccctcctctcacac
atgcaaatagagccaccaac
gcccacccaccaaatcatcg
tgcatttccctttgggaatc
ttgccaacctaccaatgtgc
gcttccatccatatgcgtcatc
cctcactgacatcctgcaac
tcgctggctgtttcactgac
ccacttctgacttccacctc
ttcagacccatgagggatgg
gatagccatgtggcggagac
gccaagtgcttgcaaataag
gtcacaaggcctcacacaag
ggatgggaaatgtcatcctg
ccactctgtcctgtctggtc
tggaaccatttgtgtagcag
gcactggtgaatcaaccaac
tgtacccaaacagggcatag
acttccaacggaagcagaga
ctcattccctccctggattc
tctcttcctggcctctcttg
aagggcttcaagcacatctc
tttcatggtcccttctaccc
gctgtaatggatcccagagg
cttgcaccattatggcagtg
acagcagcaggcatgatttg
atgggattcagcaaagcaac
ccttgacctcatctggtttg
ggaaacgcctttatgaatcc
tgcacatgctttctctcacc
caggacatggtggcacatac
tgccaaacgttgtagggttc
cctgcaaacacagacaccac
tactcccatgctacacgaacc
accaatctgtggagttcgtg
aaaagaaatgttgacggttaagagg
gatcctgagaaccaggcaatc
tctgcctttgcacagaagtg

115 bp
153 bp
235 bp
189 bp
105 bp
221 bp
228 bp
281 bp
190 bp
189 bp
234 bp
288 bp
229 bp
898 bp
320 bp
189 bp
173 bp
117 bp
219 bp
372 bp
186 bp
106 bp
184 bp
152 bp
167 bp
166 bp
248 bp
169 bp
172 bp
151 bp
354 bp
182 bp
210 bp
172 bp
214 bp
211 bp
186 bp
191 bp
152 bp
233 bp
155 bp
214 bp
401 bp
210 bp
459 bp
167 bp
185 bp

60430673-60430787
60428334-60428486
60426799-60427033
60425655-60425843
60425133-60425237
60424338-60424558
60423868-60424095
60422947-60423227
60422224-60422413
60421524-60421712
60420991-60421224
60420568-60420855
60419930-60420158
60418490-60419387
60418157-60418476
60417430-60417618
60417177-60417349
60416114-60416230
60415207-60415425
60412939-60413310
60411968-60412153
60411741-60411846
60410906-60411089
60410205-60410356
60409773-60409939
60408987-60409152
60408117-60408364
60407606-60407774
60407024-60407195
60406657-60406807
60405479-60405832
60404781-60404962
60403565-60403774
60403067-60403238
60402408-60402621
60401027-60401237
60400567-60400752
60399843-60400033
60398637-60398788
60397828-60398060
60397213-60397367
60396578-60396791
60395542-60395942
60395103-60395312
60394346-60394840
60392054-60392220
60389802-60389986
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SET 15B.1
SET 15B.2
SET 15B.3
SET 15C
SET 15D
SET 16
SET 17

aagctgcatgaagacaaacc
gtgagtgacaagcccagatg
aggcaccaatttctatgcag
gcacctctgctcagctcttc
cctgctcacctttctgattgc
gattgtggagggtgggtgtg
taagtgaaaagaaagctctcagcaa

tggaagccaatagtccaagc
acttccatggccctaactcc
caggatcacaccatttgcac
tggggatggcagtactctgg
gactgccatgggaggacttg
caatgccagtgtccatgctc
agtttaaagcctgaaaaccaagcta

174 bp
227 bp
285 bp
539 bp
174 bp
204 bp
336 bp

60388817-60388990
60387737-60387963
60386441-60386725
60385791-60386329
60385168-60385341
60384099-60384302
60383452-60383787

Gray shading signifies an original primer set used for identification of intact YAC in
AMC319 as well as in initial narrowing PCR.
All primer locations within chromosome 3 identified by the UCSC genome browser, build
hg19.

Table 5. Primers used to amplify regions of FRA7H within YAC.
Primer Set
SET 1
SET 2
SET 2.1
SET 2.2
SET 2.2.1
SET 3
SET 3.0.1
SET 3.1
SET 3.1.1
SET 3.2
SET 4
SET4.0.1
SET 4.1
SET 4.2
SET 4.2.1
SET 5
SET 5.0.1
SET 5.1
SET 5.1.1
SET 5.2
SET 5.2.1
SET 6
SET 6.0.1
SET 6.1
SET 6.2
SET6.2.1
SET 7
SET 7.0.1
SET 7.1
SET 7.2
SET 8
SET 9
SET 9.1

	
  

Forward Primer
tgaaggcctgactcccaatg
gtctttgtccaaggttgaatgattg
ccagttgtcctcctttggtg
agtgactgcagggcatctcc
agcagagggagatggtgcag
ttctccacattcttcagatctttgc
tgtcctggctctgagaaacg
tggatgccgcagtgtatctg
ggccaacgtggtgaaacaac
gtacccttgccaaagatcag
actgaactcttgactttgggctctc
accaccatgcgtaatcatcc
ctcgcccagcctaatgaagg
cactgcccactctccacctc
atggacacgggttgatggac
cttggtctggtatttgtggcataac
tgaccaggagcacctctagc
acacgccaaatgcaccaaag
ccaagccagtgctcttggtc
gcacatcatgcctaggttgc
aggctggactcagcgtgttc
gcttcacttcagagcatggatactg
ttccaggtccctgactcttg
tgtgaacgaatgggtggatg
gggtgatgggagatgcagac
ggcattgaatgtccctggtc
caaatgtgctgtgggtataggagag
cccgaagtgccagtctgaag
ctgcgtgctagtgcagatgg
agaggctctgcatgctcctg
ttggtgagctatttggtgctacttc
aacctgaaggaaaccctctctgtag
tgtgggacagttctggttgc

Reverse Primer
gttcctggtgagggctttcc
aaaggcttactgtgtgtttcagacg
attcccagggtggctgtaag
atgccgaacaagccaggaac
cgactgcaagcatcacatgg
aaacccatcagatgacaatacatgg
ttcagtagccacctggaagc
ccaaagcaggattcatgtcc
gcaatggtgcatctgctcac
tggaggcatcatacttcctg
atatatgacctgagccaggacaacc
gctgggctggtcttcaactc
aggcacggattggttcattg
ccttggacacgaggaaggac
aaatggcccaaaggtcgatg
gagcacaaagaagaaagttgctcag
tgcagcctcttgtctgtgac
gcctggcatagagcaacacc
tggcaggtgctgaagtatgg
cttccttcctccagcagcac
agtgcagccctcatttggtc
ctttactggtgaggactgggaagac
cccattcccaccactgtatc
gtgaggctcccagacacagg
ctttccatttggcctccttg
ggccagtttcctgtgcagac
ggacggcattaatgagcttctattc
attgtcccagacgcaagctc
ccggctaaagcatttggaac
cactgcaggtgaaacactgg
tgctctgtcctttataccattcagc
cctagttcaggcaacacttgaagac
ttcaggccaggagggagatg

Size
195 bp
171 bp
214 bp
165 bp
176 bp
171 bp
206 bp
204 bp
152 bp
162 bp
246 bp
452 bp
612 bp
198 bp
224 bp
225 bp
162 bp
244 bp
170 bp
217 bp
230 bp
150 bp
227 bp
151 bp
203 bp
179 bp
152 bp
207 bp
198 bp
160 bp
154 bp
182 bp
152 bp

Location on Chr7:
130700571-130700765
130693522-130693692
130686505-130686718
130679098-130679262
130675384-130675559
130671715-130671885
130668361-130668566
130665274-130665477
130661953-130662104
130658189-130658350
130651385-130651630
130647825-130648276
130643850-130644461
130636063-130636260
130632701-130632924
130628972-130629196
130625691-130625852
130622056-130622299
130618018-130618187
130615174-130615390
130611867-130612096
130608776-130608925
130605062-130605288
130601343-130601493
130594214-130594416
130590562-130590740
130587756-130587907
130584101-130584307
130580857-130581054
130573443-130573602
130567350-130567503
130550200-130550381
130542216-130542367
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SET 9.1.1
SET 9.2
SET 10
SET 10.0.1
SET 10.1
SET 10.2
SET 11
SET 12
SET 13
SET 14
SET 14.1
SET 14.2
SET 14.2.1
SET 15
SET 16

ggcgactgtgtgttctgtgg
gagccagcatttcccattcc
tatagaacaagctgggaggtacacg
aacccaggagttccaagctg
aaggcaggcagatgttggtc
cactggacccaggcttcaac
acccattatcccataaacctgaatg
ctgaggtacctggtcatcttattgg
tcccactgacagtaatagaccatcg
cctgacaccgttcaaagcattatag
ccgttgaactgtgtttgcac
gcttcaaccctgtgctaggc
tctcatccaaaccgtcacag
attatgaaccgaaagacatgtcagg
agatggttgcttggagaacg

ggccactcagtgtgttaggc
caatgtgctctgccttgtgg
aattcagcccactgctaggtaactc
accgtgcccagctaacacac
tgcttcatgggcatcctttc
ttgcaggaggaggtctggag
ttcctctgtctaggtcatcttgtgg
aagtgcagtatcttgtctggagtgc
gtggtctgagagtctggttggtatg
tatctcctgatatccctggcttctc
gcaagtcttccatggattgg
agcaatgatgggtggagtcg
tgaacctacccttgcattcc
ggtaatggtaacagagcgaaactcc
gtggccgataggaatgcttg

245 bp
210 bp
175 bp
249 bp
168 bp
197 bp
212 bp
192 bp
241 bp
235 bp
370 bp
229 bp
208 bp
185 bp
300 bp

130537901-130538145
130533424-130533633
130525241-130525415
130521704-130521952
130519327-130519494
130514111-130514307
130508502-130508713
130487464-130487655
130463479-130463719
130441222-130441456
130433502-130433871
130426578-130426806
130423016-130423223
130419143-130419327
130412430-130412729

Gray shading signifies an original primer set used for identification of intact YAC in Y408
as well as in initial narrowing PCR.
All primer locations within chromosome 7 identified by the UCSC genome browser, build
hg19.
	
  
2.9 Identification of Break Point Ends
A) Telomere PCR
Standard PCR using the primer sets in Tables 4 and 5 was used to narrow each YAC
break location to within a 6 kb region. Deletion of exo1 and sgs1 within the yeast working
strain reduced the resection of 5’ DNA to ensure that break sites that were identified would
be close to actual break locations, and the pif1-m2 genetic modification increased the
frequency of yeast telomere addition at break locations. I identified the exact location of
telomere addition in broken YACs by telomere PCR amplification. For these PCR reactions,
the forward primer of the last primer set with a positive product was paired with a reverse
telomere primer. These reverse primers were designed due to their homology with yeast
telomere repetitive sequence. Four reverse telomere primers that have been previously
published were used (Casper et al., 2009; Schmidt and Kolodner, 2006), each in a separate
reaction with the last working human forward primer.

	
  

49	
  

The four reverse primers used where:
Telo 1-r 5’ CACCACACCCACCACCACACCCAC,
2-ARBM-r 5’ GGCCACGCGTCGACTAGTACMMMMMMMMMMAAAAA,
3-ARBA-r 5’ GGCCACGCGTCGACTAGTACNNNNNNNNNNAAAAA,
4-ARBC-r 5’ GGCCACGCGTCGACTAGTACNNNNNNNNNNCCCCC.
Note: M designates an A or C, N designates A,T,C or G
The telomere PCR was carried in 20 µl reactions containing 100 ng of genomically
harvested DNA, 0.4 µM final concentration of each primer, and 10U/ µl GoTaq Green master
mix (Promega Corporation, Madison, WI). The PCR cycling conditions were 94o C for 2
min, followed by 35 cycles at 94o C for 30 sec, 55o C for 30 sec, and 72o C for 1 min, with a
final extension at 72o C for 7 min. These reactions were separated by agarose gel
electrophoresis under the same conditions stated above for identification of positive PCR
products. Control PCR reactions were completed by taking the unbroken strains (either
AMC319 or Y408) and pairing them with the same reaction components as the broken strains
being tested. Positive PCR products from the experimental strains that were not present in
the control reactions were cut out of the agarose gel and extracted using a Gel DNA recovery
Kit (Zymo Research, Irvine, CA).
B) Cloning and Sequencing of Telomere PCR Products
Purified telomere PCR products were inserted into a pCR™2.1-TOPO® vector
(Invitrogen TOPO® TA Cloning® Kit. By Life Technologies, Carlsbad, CA). The reaction
consisted of 4 µl of extracted DNA from Telomere PCR reaction, 1 µl of salt solution (1.2 M
NaCl; 0.06 M MgCl2) and 1 µl of pCR™2.1-TOPO® vector. The reaction set for 5 min at
room temperature. Vectors with inserted Telomere PCR product were transformed into One
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Shot® Mach1™ -T1R Competent Cells (Invitrogen TOPO® TA Cloning® Kit. By Life
Technologies, Carlsbad, CA) and grown overnight at 37o C on LB+ampicillin+Xgal plates
(Table 3). White colonies were patched onto LB+ampicillin+Xgal plates and grown over
night at 37o C for verification of transformed cells. 3 ml of LB+ampicillin liquid media was
inoculated with transformed cells and incubated at 37o C over night. Plasmids were extracted
using a Zyppy™ Plasmid Miniprep Kit (Zymo Research, Irvine, CA). Purified plasmids
containing telomere PCR products were sequenced by Eton Bioscience Inc. Identification of
specific base pair transition from inserted human DNA to yeast telomere DNA was
conducted using the Blat function of the USCS genome browser (http://genome.ucsc.edu/).
Sequence results were blasted and sequence alinement to the human genome was used to
identify the extent of human DNA within the telomere PCR product.
2.10 Data Analyses Testing Hypothesis 1
A) Flexibility Peak Analysis and Identification of Distance To Break Sites.
The Twistflex program was used to determine the locations of flexibility peaks in the
FRA3B and FRA7H sequences on the YACs (http://margalit.huji.ac.il/) (Mishmar et al.,
1998). The default threshold value to identify a flexibility peak was set at 13.7o. Additional
analysis was conducted using threshold values of 14o and 16o. All other parameters were left
at default values including window size (100 bp), leap (1 bp), sequence length for
normalizing the results (10000 bp), sequence length for displaying the discrete summation
(10000 bp), minimal number of peaks in a cluster (3) and maximal distance between peaks in
a cluster (5000 bp). I analyzed the reverse complement of FRA3B region (chr3: 61,016,76660,384,099) and the reverse complement of the FRA7H region (chr7: 130,412,430130,700,765). The reverse complement sequence of the fragile site regions was analyzed
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because both inserts were oriented into the YAC in the reverse complement direction. Dr.
Charles Jacobs (Henry Ford Community College) developed an Excel® program to analyze
the average distance from YAC break regions to the closest flexibility peaks located
centromere-distal within the human inserts of each YAC. I only analyzed distances from
breaks to distal flexibility peaks, and not distance from breaks to centromere-proximal
flexibility peaks, because the broken YACs we are able to identify must retain the
centromere, and thus the breaks we detect can only result from replication stalling and
collapse at a secondary structure centromere-distal to the replication fork. The program was
created in the Excel® and consisted of the following analyses (column values are different
between the FRA3B and FRA7H analysis due to differences in number of flexibility peaks;
description below is representative of the FRA3B template):
In table A:
1. Column B, the list of yeast strain names with broken YACs is entered.
2. Column C is the base number of the centromere-proximal end of the Critical Break
Area (CBA) in the YAC (The Critical Break Area (CBA) is the distance between the
5’ end of the last reverse primer that was positive in the YAC insert to the 5’ end of
the first reverse primer that was negative in the YAC insert plus 4 kb, unless a
telomere had been added, in which case 4 kb was added to the last human base before
telomere addition. The analysis of Critical Break Area is discussed in detail below,
in the results section).
3. Column D is the total length in bp of the CBA.
4. Columns E-V calculated the distance from high endpoint of CBA to the most
centromere-proximal base of each known flexibility peak.
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In table B:
1. Column B, the list of yeast strain names with broken YACs is entered.
2. Column C is the base number of the centromere-distal end of the CBA in the YAC,
the proximal end of the CBA (Column C, Table A) minus CBA in table A (Column
D).
3. Columns E-V calculated the distance from centromere-distal end of CBA in the YAC
(Column C of table B) to each known flexibility peak.
In table C:
1. For each cell in Columns E-V in table A, if the value in the cell was less than zero,
then table C displayed (exclude), otherwise it displayed the distance as a positive
value.
In table D:
1. For each cell in Columns E-V in table B, if the value in the cell was less than zero,
then table D displayed (exclude), otherwise it displayed the distance as a positive
value.
In table E:
1. Column E identified the shortest distance from the centromere-proximal end of the
CBA in the YAC to a distal flexibility peak.
2. Column F determined if the CBA contains a flexibility peak within it. The
identification of distances to distal flexibility peaks from each end of the CBA
allowed for the proper identification of a flexibility peak located within the CBA. If a
distance from the proximal end of the CBA was positive, and the distance from the
distal end was negative, I could identify and designate a zero base pair distance.
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3. Column G identified the shortest distance from the centromere-distal end of the CBA
in the YAC to a distal flexibility peak.
4. Identifies the shortest distance from a CBA to a distal flexibility peak. The column is
averaged to identify the average distance from all CBAs within the data set to a distal
flexibilty peak.
This analysis was completed for the experimental set of 27 CBAs for FRA3B and 29
CBAs for FRA7H (3 FRA3B CBAs and 1 FRA7H CBA were centromere distal to the last
identified flexibility peak and therefore were omitted from the analysis). Control Non-Break
Areas (NBAs) that are size-matched to the CBAs were randomly generated. The NBAs were
drawn from sequence between the centromere-proximal end of the YAC insert and the most
centromere-distal flexibility peak. For the FRA3B region, random numbers were generated
between (chr3: 61,016,766-60,401,538) and for FRA7H random numbers were generated
between (chr7: 130,700,765-130,449,105). Numbers were generated using the integer finder
page of the Random.org web server (http://www.random.org/integers/). 100 sets of 27 or 29
control non-break areas (NBAs) for each fragile site were randomly generated. For each
NBA set, average distance to the nearest distal flexibility peak was calculated using the
Excel® program described above. A Monte Carlo frequency distribution was used to test the
significance of the average distance from experimental CBAs to distal flexibility peaks when
compared to 100 sets of control NBAs, for each fragile site. I analyzed the reverse
complement strand of FRA3B region (chr3: 61,016,766-60,384,099) and of the FRA7H
region (chr7: 130,412,430-130,700,765).
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B) Standard Initiation Duplex Destabilization (SIDD) Analysis
Spontaneous denaturation of DNA can form single-stranded DNA that could
potentially permit secondary structure formation. These secondary structures could stall
DNA replication, leading to collapsed forks and DNA breaks. I analyzed the potential for
spontaneous DNA denaturation of flexibility peak sequence for both fragile sites using the
WebSIDD server (http://benham.genomecenter.ucdavis.edu/sibz/). The SIDD algorithm
calculates the statistical mechanical equilibrium properties of the strand separation transition
in a DNA sequence under negative superhelical stress (Bi and Benham, 2004). The
algorithm identifies the amount of energy needed to randomly denature a double-stranded
DNA sequence based on the base pairing characteristics of the sequence (G(x), kcal/mol), as
well as the probability of denaturation occurring within each segment of the sequence (P(x)).
All parameters in the program were kept at their default values including DNA type (linear),
temperature (310 K) and superhelical density (-0.055). The minimum G(x) of each
flexibility peak was determined. The experimental set of minimum G(x) calculations from 18
FRA3B flexibility peaks and 7 FRA7H flexibility peaks was identified. The average
minimum G(x) for FRA3B flexibility peaks was compared to the average minimum G(x) for
FRA7H flexibility peaks. A two-tailed Mann-Whitney U Test/Wilcoxon Rank Sum Test was
used to determine if there was a difference between the minimum G(x) between the FRA3B
and FRA7H flexibility peaks.
C) mFOLD Analysis
The distribution of breaks within each YAC insert could be due to single stranded
DNA forming extremely stable secondary structures. I performed an analysis to determine
stable secondary structure formation of DNA when single stranded using the DNA Folding
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Form from the mFOLD Web Server (http://mfold.rna.albany.edu/?q=mfold/DNA-FoldingForm). The algorithm parameters were kept at default values. This program uses algorithms
to identify stable secondary structures that could form when DNA was single stranded
(Zuker, 2003) and also calculates the free energy values (kcal/mol) associated with each
secondary structure formation. Lower free energy values are representative of more stable
secondary structures (SantaLucia, 1998). Experimental CBAs were split into 800 bp
sequential sections. 800 bp sections were selected to represent extended segments of single
stranded DNA between the unwinding helicase and replicating DNA polymerase that may
occur under replication stress. Under normal replication conditions, the Okazaki initiation
zone of the replication fork, comprised of single stranded DNA, is approximately 300 bp in
yeast (Anderson and DePamphilis, 1979; Hay and DePamphilis, 1982). From each 800 bp
segment, the lowest free energy value was selected, representing the most stable secondary
structure. This process was completed for all 800 bp segments derived from single stranded
DNA from both the positive and negative strands of the CBAs. The lowest free energy value
of all the segments for each CBA was selected. The lowest free energy values for the 30
experimental strain CBAs were averaged for both FRA3B and FRA7H. These average low
free energy values were compared to the average low free energy value for a set of 30 control
NBAs for both FRA3B and FRA7H.
2.11 Data Analysis Testing Hypothesis 2
A) Potential Origin Analysis and Identification of Distance To Break Sites.
The	
  human	
  DNA	
  inserted	
  on	
  the	
  YACs	
  could	
  contain	
  sequences	
  that	
  behave	
  as	
  
yeast	
  origin	
  sites.	
  	
  Each	
  yeast	
  autonomously	
  replicating	
  sequence	
  (origin	
  site)	
  contains	
  
an	
  autonomous	
  consensus	
  sequence	
  (ACS)	
  consisting	
  of	
  an	
  11	
  bp	
  sequence,	
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5’(A/T)TTTAT(A/G)TTT(A/T)	
  (Theis	
  and	
  Newlon,	
  1994,	
  1997).	
  	
  This	
  sequence	
  is	
  part	
  
of	
  domain	
  A.	
  	
  Alterations	
  to	
  the	
  consensus	
  sequence	
  greatly	
  reduce	
  origin	
  function	
  
(Chang	
  et	
  al.,	
  2008).	
  	
  The	
  region	
  to	
  the	
  3’	
  end	
  of	
  origin	
  domain	
  A	
  is	
  considered	
  domain	
  
B,	
  and	
  is	
  AT	
  rich	
  (Breier	
  et	
  al.,	
  2004;	
  Newlon	
  and	
  Theis,	
  1993;	
  Xu	
  et	
  al.,	
  2006).	
  	
  The	
  
molecular	
  characterization	
  of	
  domain	
  B	
  is	
  poorly	
  understood.	
  
I analyzed 6 verified yeast origins identified by the Saccharomyces Genome Database
(www.yeastgenome.org/). I obtained sequence information from ARS1, ARS300, ARS305,
ARS309, ARS404 and ARS600. I used these known origins because the database identified
the exact location of the ACS within each origin. I determined the AT-richness of the 100 bp
regions at the 3’ end of the ACS and determined the lowest to be 67%. Using NCBI BLAST
(http://blast.ncbi.nlm.nih.gov), comparing two segments of DNA, I identified positions on the
human inserts in the YACs that contained any of the eight possible combinations of the 11 bp
yeast ACS. I analyzed both the positive and negative strands of the DNA insert to account for
the fact that the origins may be read from either stand in either direction. I then took the
positive matches to the Yeast ACS elements and analyzed 100 bp regions immediately 3’ to
the ACS locations for AT richness. I classified potential origin sites in the YAC inserts as
those containing the ACS and containing at least 67% AT-richness in the 100 bp immediately
3’ of the ACS. Dr. Charles Jacobs developed an Excel® program to analyze the average
distance from CBAs in each YAC to potential origins located within the human inserts of
each YAC. The program consisted of the following analyses (column values are different
between the FRA3B and FRA7H analysis due to differences in the number of potential
origins, description below is representative of the FRA3B YAC):
In table A:
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1. Column B, list of yeast strain names with broken YACs is entered.
2. Column C is the base number of the centromere-proximal end of the CBA in the
YAC.
3. Column D is the total length in bp of the CBA.
4. Columns E-AA calculates the distance from centromere-proximal end of the CBA to
each potential origin site.
In table B:
1. Column B, list of yeast strain names with broken YACs is entered.
2. Column C is the base number of the centromere-distal end of the CBA in the YAC.
3. Columns E-AA calculated the distance from the centromere-distal end of CBA (to
each potential origin site.
In table C:
1. All columns report the absolute value of the distance from the centromere-distal end
of each CBA to potential origin sites.
In table D:
1. All columns report the absolute value of the distances from the centromere-distal end
of each CBA to potential origin sites.
Table E
1. Column E reported the distance to the closest potential origin site to the centromereproximal end of each CBA.
2. Column F reported the distance to the closest potential origin site to the centromeredistal end of each CBA.
3. Column G identified the smallest value between columns E and F.
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4. Columns H and I took the smallest distance identified in column G and found the
location of the potential origin indicated by that distance. Since Excel®	
  does	
  not	
  
allow	
  searching	
  of	
  2-‐dimentional	
  arrays,	
  It	
  first	
  searched	
  if	
  the	
  distance	
  
identified	
  in	
  column	
  G	
  was	
  calculated	
  from	
  the	
  proximal	
  or	
  distal	
  end	
  of	
  the	
  CBA.	
  	
  
Once	
  identified,	
  they	
  return	
  the	
  location	
  of	
  the	
  potential	
  origin	
  from	
  row	
  3.	
  	
  
5. Columns J calculated the vector distance from the centromere-proximal end of the
CBA to that closest potential origin identified in columns H and I.
6. Columns K calculated the vector distance from the centromere-distal end of the CBA
to that closest potential origin identified in columns H and I.
7. Column L identified if a potential origin fell within the CBA region. It does so by
identifying a positive number in column J and a negative number in column K.
8. In a few circumstances the distance from a potential origin located outside of the
CBA to the centromere-distal end was shorter than the distance from a potential
origin located inside of the CBA to the centromere-distal end. Columns M, P and Q
were used to make sure that the program gave preference to an origin within the CBA
over any external origin even ones that might be closer to the centromere-distal end of
the CBA. Column Q was averaged to identify the average distance from a set of
CBAs to the closest potential origins.
This analysis was completed for the experimental set of 30 CBAs for FRA3B and 30
CBAs for FRA7H. 100 sets of Non Break Areas (NBA) (each set containing 30 control
NBAs) for each fragile site were randomly generated using the same procedure explained
above. Random numbers were created from a range of (chr3: 61,016,766-60,384,099) for the
FRA3B region and (chr7: 130,412,430-130,700,765) for the FRA7H region. A Monte Carlo
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frequency distribution was used to test the significance of the distance from experimental
CBAs to potential origin sites when compared to 100 sets of control NBAs to potential origin
sites, for each fragile site.
2.12 Additional Analysis of Break Locations.
A) Analysis of GT Richness of Critical Break Areas
Double-stranded breaks can be capped and maintained by telomere addition (Chung
et al., 2010). Telomere addition allows for protection against DNA degradation. Yeast
telomeres consist of four main components, (1) a 300 bp ± 75 bp of a repeated C1-3A/TG1-3
repeated sequence. This sequence is heterogenous due to the partial alignment of RNA
template along with the difference in extension cycles (Förstemann and Lingner, 2001).
Yeast telomeres can contain a Y’ subtelomeric sequence of 1-4 repeats directly internal from
the C1-3A/TG1-3 repeated sequence. The Y’ region is either long (6.7 kb) or short (5.2 kb)
(Chan and Tye, 1983a, 1983b). All yeast telomeres contain a X region which is extrememly
heterogeneous and is comprised of a set of repeats internal to the C1-3A/TG1-3 repeat and Y’
sequences (Walmsley et al., 1984). The ends of yeast telomeres consist of a 3’ G tail that
extends from 30-100 nucleotides in size (Wellinger et al., 1993).Telomere addition is known
to occur preferentially at GT-rich locations (Kramer and Haber, 1993) that contain telomere
seeding sequences. GT richness analysis was conducted to determine if the break locations
identified are correlated with locations that are ideal for telomere addition. The sequence of
each CBA was obtained using the UCSC genome browser (http://genome.ucsc.edu/). G and
T content were counted and expressed as a percentage compared to the total sequence in the
YAC insert. This procedure was conducted in all 30 experimental CBAs for both FRA3B
and FRA7H along with 30 random control non-break areas for both FRA3B and FRA7H.
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Chapter 3
Results
3.1 Initial Characterization of the YACs in Yeast Strains AMC319 and Y408
Before experimental procedures for inducing breaks in human inserts of YACs
carried in my working strains could begin, I first needed to test the extent of human DNA
present in each YAC. This was completed to determine if the working strains contained
intact analyzable regions of human DNA. Experimental yeast strain AMC319 contains YAC
850a6. Previous research showed that YAC 850a6 carried a 1.3 Mb segment of human
chromosome 3 that contains exons 1-5 of the FHIT gene (Zimonjic et al., 1997). Rajula
(2011) determined that the human sequence inserted on YAC 850a6 is in an inverted
orientation relative to its position on the human chromosome. This means that primers with
smaller basepair numbers are located centromere-distal on the YAC compared to primers
with larger numbers. Rajula (2011) used primers from Durkin et al. (2008) to determine that
YAC 850a6 contained an inserted chromosome 3 sequence at least from bp 61,016,766 (the
centromere-proximal ligation point of the inserted human DNA to the YAC) to 60,394,840
(the centromere-distal ligation point of the inserted human DNA to the YAC), which includes
a large portion of FRA3B. I created three new primer sets and used these along with the
original primer sets used by Rajula (2011) to determine if there was a larger region of human
chromosome 3 present in the YAC in yeast strain AMC319. Primer set 16 was created to get
a better understanding to the extent of human DNA along the centromere-distal end of the
insert. Primer sets 11 and 13 were created to replace ones previously used by Rajula (2011).
These new primer sets gave more reliable identification of the intact YAC at those positions.
To avoid confusion, I renamed primer sets originally described by Rajula (2011)(Table 6).
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Products were amplified through standard PCR and separated through gel electrophoresis
(Figure 16). The positive band at primer set 16 showed that the YAC 850a6 contained more
sequence from human chromosome 3 than previously described, extending the known distal
end of the insert from chromosome 3 base 60,394,840 (Rajula, 2011) to base 60,384,099.
Primer set one does not identify the centromere-proximal end of the human insert. The
distribution of primer sets along the last 632 kb of the 1.3 Mb human insert are displayed in
Figure 13. Primer set 1 was utilized as the centromere-proximal end of the analyzable region
because previous research by Rajula (2011) indicated that no breaks occurred centromereproximal to that location. Kayleigh Watson of the Casper lab created primer sets that were
centromere-proximal to that location and determined that the entire human insert was
chromosome 3. This testing identified that the entire human insert was comprised exclusively
of one piece of chromosome 3; therefore ruling out the possiblility of multiple chromosome
pieces stuck together. No product at primer set 17 indicates that the YAC does not include
this region of human chromosome 3 and therefore identifies the end of the YAC insert. This
analysis indicated that AMC319 contained the correct 632 kb segment of chromosome 3 that
was previously used by Rajula (2011). This segment of DNA contained the approximately
500 kb of sequence suggested to be FRA3B. Previous research by Rajula (2011) showed that
breaks do occur within the portion of FRA3B present on the YAC; therefore AMC319 is
useful for experimental analysis of breaks within the fragile site.
I also needed to determine the extent of the FRA7H human DNA insert within
working strain Y408. Experimental yeast strain Y408 contains YAC yWSS11. Previous
research had identified FRA7H within a 161 kb sequence along the right arm of chromosome
7 (Hellman et al., 2000), and that some portion of this fragile site is present in YAC
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yWSS11. I designed 18 new primer sets to analyze the extent of human chromosome 7
present on the YAC in strain Y408. These primer sets span approximately 300 kb on human
chromosome 7 from base 130,708,318 (the centromere-proximal ligation point of the inserted
human DNA to the YAC) to 130,405,990 (the centromere-distal ligation point of the inserted
human DNA to the YAC), and the sets are spaced approximately 20 kb apart (Table 7). The
extent of chromosome 7 located on YAC yWSS11 is depicted in Figure 17A. Y408
contained positive PCR products from primer sets 1 though 16, approximately 288 kb. This
showed that the YAC contained inserted human chromosome 7 from base 130,700,765130,412,430. Y408 did not contain primer sets 0 or 17 therefore these sections of
chromosome 7 are not present on the YAC. Previous research in the Casper lab identified
the FRA7H YAC to be 730 kb. This suggested that the human insert was made of more than
one section of the human genome. The 288 kb segment of chromosome 7 could be located
on the centromere-proximal or centromere-distal portion of the human insert. Ellen Younkin
of the Casper lab identified that the 288 kb segment of chromosome 7 was on the
centromere-distal portion of the human insert. She extracted total Genomic DNA by
standard protocol (Lõoke et al., 2011), ran the DNA by Pulse Field Gel Electrophoresis
(PFGE) (Schwartz and Cantor, 1984) and then identified broken FRA7H YACs through
southern blotting techniques (Figure 17B). Molecular weights of broken FRA7H YAC strains
suggest that the 288 kb segment of chromosome 7 is located on the centromere-distal portion
of the human insert. Low molecular weight bands in lanes 6 and 14 could result from an
internal deletion in the human insert. The probe was created from the TRP1 genetic marker
located on the left arm of the FRA7H YAC. The row of bands at approximately 1,500 kb
represents a mutant trp1 marker located on yeast chromosome IV and is a control for
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hybridization of the probe. Good separation of bands occurred from 500 kb and below.
Larger segments of DNA are condensed together at the top of the blot. This inserted human
DNA on the YAC contains the entire FRA7H fragile site (Hellman et al., 2000), therefore
this YAC is useful for analysis of breaks within this fragile site.
Table 6. Primer sets used to characterize the human DNA insert on YAC 850a6, in
yeast strain AMC319. Primer sets 11, 13 and 16 were newly created to get a
better identification of the FRA3B insert. Primer sets used in Rajula (2011) have
been re-named.
Original
Primer Set
Name from
Rajula (2011)
Intron 3-1
Intron 3-7
Intron 3-13
Intron 3-19
Intron 4-6
Intron 4-15
Intron 4-19
Intron 4-26
Intron 4-35
Intron 4-40
Intron 4-46
not applicable
Intron 4-51
Exon 5
Intron 5-5
not applicable
Intron 5-12
Intron 5-18
not applicable
Intron 5-19

	
  

New Primer Set
Name

Size

Location on Chr3:

Primer Set 1

639 bp

61016127-61016766

Primer Set 1.1
Primer Set 2
Primer Set 3
Primer Set 4
Primer Set 5
Primer Set 6
Primer Set 7
Primer Set 8
Primer Set 9
Primer Set 10
Primer Set 11
Primer Set 11.A
Primer Set 12
Not used
Primer Set 13
Primer Set 14
Primer Set 15
Primer Set 16
Primer Set 17

151 bp
227 bp
343 bp
443 bp
319 bp
207 bp
167 bp
180 bp
233 bp
363 bp
901 bp
162 bp
493 bp
153 bp
126 bp
235 bp
459 bp
204 bp
336 bp

60879994-60880144
60842170-60842396
60813166-60813508
60778585-60779017
60750667-60750985
60725097-60725303
60711731-60711897
60673942-60674121
60647221-60647453
60606504-60606866
60566649-60566810
60563626-60564526
60522300-60522792
60492419-60492571
60492393-60492518
60426799-60427033
60394346-60394840
60384099-60384302
60383452-60383787
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Figure 16. Analysis of YAC 850a6 within yeast strain AMC319.(Left gel) Lane 1 is a 100
bp ladder in which the 500 bp band is most intense. Each lane after the ladder consists of
products generated by PCR reactions of 16 primer sets used to identify the extent of
human DNA present on YAC 850a6 in AMC319. (Right gel) Lane 1 is a 100 bp ladder.
Lane 2 and 3 consist of products generated by PCR reactions of primer set 16 and set 17
respectively, used to identify the end of the human DNA insert present in AMC319

Table 7. Primer sets used to characterize the human DNA insert on YAC yWSS11, in yeast
strain Y408.

	
  

Primer Set Name

Size

Location on Chr7:

Primer Set 0

248 bp

130708171-130708318

Primer Set 1
Primer Set 2
Primer Set 3
Primer Set 4
Primer Set 5
Primer Set 6
Primer Set 7
Primer Set 8
Primer Set 9
Primer Set 10
Primer Set 11
Primer Set 12
Primer Set 13

195 bp
171 bp
171 bp
246 bp
225 bp
150 bp
152 bp
154 bp
182 bp
175 bp
212 bp
192 bp
241 bp

130700571-130700765
130693522-130693692
130671715-130671885
130651385-130651630
130628972-130629196
130608776-130608925
130587756-130587907
130567350-130567503
130550200-130550381
130525241-130525415
130508502-130508713
130487464-130487655
130463479-130463719
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Primer Set 14
Primer Set 15
Primer Set 16
Primer Set 17

235 bp
185 bp
300 bp
155 bp

130441222-130441456
130419143-130419327
130412430-130412729
130405990-130406144

Figure 17. Analysis of YAC yWSS11 within working strain Y408. (A) Lane 1 is a 100 bp
ladder. Each lane after the ladder consists of products generated by PCR reactions of 18
primer sets used to identify the extent of human DNA from chromosome 7 present on the
YAC yWSS11 (approximately 288 kb). (B ) Southern Blot of FRA7H YAC strains. Lane 1
is a λ ladder in which 1,500 band is most intense. Lane 2 is a control non-broken FRA7H
YAC. Lanes 3-21 are broken FRA7H YACs. The majority of broken YACs have lengths
between 450-550 kb.
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3.2 Identification of Breakage Locations Within Human Insert.
A) Initial PCR Testing
Breaks within fragile site regions were induced by plating yeast strains containing
YACs onto low galactose growth media overnight. Strains that contained the phenotype
indicating a broken YAC (Trp+, Ura-, 5-FOAR, HygR) were then tested by initial PCR to
determine if a break occurred within the analyzable region of the inserted human DNA. Each
fragile site contained 16 original primer sets for break identification; only primer sets 1 and
16 were used to identify breaks occurring within human inserts. These two primer sets were
used because they were furthest apart and encompassed the entire analyzable portion of the
fragile site. It was assumed that primer sets in lost chromosome regions would not produce a
product. 30 strains with a break in FRA3B and 30 strains with a break in FRA7H were
identified by this initial PCR testing. A representative analysis of one of the strains with a
broken YAC, strain Y455 (broken FRA7H YAC), is provided (Figure 18). Primer set 1 from
the FRA7H collection is expected to produce a 195 bp product and primer set 16 is expected
to produce a 300 bp product (Table 5). Both primer sets are present within the control YAC
strain Y408 but only primer set 1 is intact within Y455. This initial PCR gives evidence that
a break has occurred between primer sets 1 and 16 in Y455.
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Figure 18. Representative example of initial PCR to identify breaks within human DNA
insert of interest using broken YAC Y455. (A) Graphic displaying the FRA7H YAC
including insert. Primer Sets 1 and 16 lie on opposite ends of the segment of chromosome
7. (B) Gel picture showing positive product for Y455 at primer set 1 and negative product
for Y455 at primer set 16. Control strain is Y408. Lane 1 is a 100 bp ladder. Outcome
suggests break in Y455 YAC must have occurred within human insert in between the two
primer sets.
B) PCR Testing of Broken YAC Strains Using 16 Original Primer Sets.
Each YAC with a break in the fragile site was further analyzed using the 16 original primer
sets in order to narrow the break location in each YAC human insert. This PCR process
allowed for narrowing of break positions within the lengthy inserts with approximately 40 kb
between primer FRA3B primer sets and approximately 18 kb between FRA7H primer sets.
FRA3B broken YACs used primer sets 1-16 from the FRA3B collection (Table 4) and
FRA7H broken YACs used primer sets 1-16 from the FRA7H collection (Table 5). A
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representative analysis of primer set 1-16 PCR, using strain Y455, shows that broken strain
Y455 has a break between primer set 6 and primer set 7. Break gap has been narrowed to
21,018 bp (Figure 19). Strain Y455 contains positive products for each primer set from 1-6.
After primer set 6, Y455 no longer creates positive PCR products suggesting that this section
of the YAC is no longer present within the broken strain. The locations of all YAC break
sites were narrowed by this PCR method.

Figure 19. Representative analysis of primer set 1-16 PCR in strain Y455. (A) Graphic
depicting the YAC including the human DNA insert of interest. Original primer sets 1-16
span the entire section of interest. (B) Lane 1 and 17 are 100 bp ladders. Each lane after
the ladder alternates from experimentally broken YAC strain Y455 and control nonbroken strain Y408.

C) Additional PCR Testing to Narrow Break Locations.
In order to narrow the distance between primer sets and more clearly define break
locations, new primer sets were designed (Tables 4 an 5). For each break within 30 FRA3B
broken YACs and 30 FRA7H broken YACs, narrowing of break locations was conducted.
Each break region was reduced to less than 6 kb with an average break region for FRA3B
broken strains of 1,090±1238 bp and an average break region for FRA7H broken strains of
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2,936±1,549 bp. Break regions are calculated as the distance from the 5’ end of the last
reverse primer to produce a positive PCR product to the 5’ end of the next reverse primer that
gave a negative product. A representative analysis of this procedure using strain Y455 shows
that broken strain Y455 has a break between primer set 6.0.1 and primer set 6.1. The new
break region is narrowed to 3,719 bp. (Figure 20).	
  

	
  
Figure 20. Representative analysis of using newly created primer sets to narrow down
break locations. (A) Graphic depicting the FRA7H broken strain Y455. Newly created
primer sets 6.0.1 and 6.1 are located between original primer sets 6 and 7 to help narrow
location of break. (B) Agarose gel picture of PCR amplification of primer sets. Lane 1 is
a 100 bp ladder. Each lane after alternates from experimentally broken YAC strain Y455
and control non-broken strain Y408.

	
  

D) Telomere PCR
PCR to identify the exact location of telomere addition at YAC breaks was conducted

on all broken YACs. Each broken YAC was analyzed using four reverse telomere primers.
In each reaction the forward primer from the last primer set to produce a positive PCR
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product was paired with one of four yeast telomere reverse primers. Yeast telomeres are very
repetitive; therefore the yeast reverse primers used were degenerate, since we can’t predict
the exact sequence of the telomere that may be added. The PCR reactions were run at a low
annealing temperature that resulted in a large opportunity for false positive bands. Each
Telomere PCR reaction was run with the experimental broken YAC as well as a non-broken
control YAC strain. The comparison of the banding patterns of the resulting gel allowed for
proper identification of a potential telomere addition. Positive experimental banding that was
not present in the non-broken control YAC strain was further analyzed. Telomere PCR of
Y455, representing a broken YAC, resulted in a positive band between the forward primer of
set 6.0.1 and the reverse telomere primer, Telo-1-r (Figure 21). The PCR reaction using the
same reagents but substituting Y455 with control non-broken FRA7H DNA from strain Y408
did not result in a positive product (Figure 21). Of the 60 strains analyzed by telomere PCR,
11 FRA3B broken YAC strains and 9 FRA7H broken YAC stains produced PCR products
that were not observed in the control non-broken YAC strains.
Telomere PCR products that were present in broken YAC strains and not in the
unbroken control were cloned and sequenced in order to determine exact location at which a
yeat telomere had added. Of 11 samples sent for sequencing for FRA3B broken strains, 9
contained sequence that identified the addition of a yeast telomere to human DNA (Table 8).
Of 10 samples sent for sequencing for FRA7H broken strains, 6 contained sequence that
identified the addition of a yeast telomere to human DNA (Table 8). Sequence from broken
YAC strains that did not show an addition of a yeast telomere to human DNA were positively
identified as sections of the yeast genome that had been amplified due to partial annealing of
primers. A representative sample of DNA sequencing from FRA3B broken YAC strain
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Y351 shows a transition from the human DNA insert to yeast telomere DNA (Figure 22).
Identification of the telomere addition allowed for the break region in these strains to be
narrowed to a single base pair in the YAC, at which yeast telomeres capped.	
  In yeast,
telomeres consist of non-specific GT repeat sequences. Telomere addition at double-strand
DNA breaks preferentially occurs at a 1-6 GT rich telomere seed sequence, used as a signal
sight for addition of the telomere, also consisting of GT content (Kramer and Haber, 1993;
Putnam et al., 2004). The use of mutations in AMC319 and Y408 reduced the resection of
DNA from a double-stranded break, but still resulted in the same preference of seed
sequences for telomere addition. I analyzed these telomere additions on broken YACs for
the presence of telomere seed sequences in the human DNA insert at the addition site for
FRA3B and FRA7H broken stains (Table 8).
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Figure 21. Representative analysis of telomere PCR using strain Y455. (A) Graphic
depicting broken FRA7H strain Y455 with a yeast telomere capping the double-stranded
break. The last forward primer from the last primer set to produce a positive PCR product
(primer set 6.0.1, in blue) is identified in a red box. This forward primer is paired with
one of four reverse yeast telomere primers identified as black in a red box. These primers
could create a positive product between the human and yeast DNA. (B) Agarose gel used
in separation of telomere PCR products. Lane 1 and 14 are 100 bp ladders. Lanes 2-5
represents Y455 with each of four reverse telomere primers, named below the lanes.
Lanes 6-9 represents a second experimentally broken YAC strain with each of four
reverse telomere primers. Lanes 10-13 are these same reactions in Y408, a control nonbroken FRA7H YAC. The positive product in lane 2 identified in the red box could be a
telomere addition due to the lack of the product in the non-broken strain.
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Figure 22. Representative sequence analysis of telomere PCR product. Red arrow and
line divide between inserted human DNA and yeast telomere DNA.
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Table 8. Yeast telomere addition to inserted human DNA for both FRA3B and FRA7H
broken strains. Bold letters in column 2 represent the yeast telomere seed sequence in the
human DNA.
	
  
FRA3B
Broken
YAC
Y340
Y351
Y357
Y387
Y389
Y392
Y402
Y441
Y444
FRA7H
Broken
YAC
Y455
Y457
Y466
Y470
Y472
Y473

Sequence where telomere was
added next to DSB
CAAACCAAGTTCCTGTGGGG
AGATCATCTTTGGCAGTGGT
CTCTCTGCAGCACCCAGAGT
AAGATGCACATATGTGGAGT
AGGTGGTCCTTGAAAGTAGG
AAACCTGCTGCCTGGGGAGG
AAATCAATTTATTTATGCAAG
TGCCTAGGGGCTAGGATGTG
ACAGAGCACAAGAGATTGTT
Sequence where telomere was
added next to DSB
TTTAGAAGACCACAGCTGGG
TGGGAGGCAAAGGCGGGTGG
AGCCAAATGTATTATGGGGT
GGGAATGTGTTTTGCAGGTG
AGAAAAGAAAGGTTGTGTGT
TCCTGCCGAGGCACTGAGAG

Beginning of telomeric sequence
added at DSB
TGTGGGTGTGGGTGTGGGGT
GTGGGTGTGGTGGTACTAGT
GTGTGGGTGTGTGTGGGTGT
GTGTGTGGGTGTGGTGTGTG
GTGTGTGGGTGTGGTGGTAC
GTGTGTGGGTGTGGTGTGTG
GGTGTGTGGGTGTGGTGGTA
TGTGGGTGTGGTGTGGGTGT
GGTGTGGGTGTGTGGGTGTG
Beginning of telomeric sequence
added at DSB
TGTGGGTGTGGGTGTGGGTT
GTGTGGTGTGTGGGTGTGTG
GTGTGGGTGTGTGGGTGTGG
TGGGTGTGGGTGTGGTGGTA
GGGTGTGTGGGGGTGTGGGT
GTGTGGGTGTGGTGGTACTA
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E) FRA3B and FRA7H Break Distributions Within the Human DNA Inserts
Strains with telomere PCR data have a break region of 0 bp, and strains in which
telomere PCR was unsuccessful have a break region of 6 kb or less. Final break locations in
the 30 strains containing broken FRA3B YACs are displayed in Table 9 and Figure 23. Final
break locations in the 30 strains containing broken FRA7H YACs are displayed in Table 10
and Figure 24. Breaks within the FRA3B human DNA concentrate towards the centromeredistal end of the 632 kb section of the insert that was analyzed. Sixty percent of the breaks
occur within the last 54 kb of the 632 kb analyzed section. The 632 kb section that was
analyzed is located on the centromere-distal end of the entire human insert, therefore breaks
are occurring near the centromere-distal end of insert (Figure 23). Breaks within the FRA7H
human DNA concentrate towards the centromere-proximal portion of 288 kb section of the
insert that was analyzed. Eighty-three percent of the breaks occur within the first 120 kb of
the 288 kb analyzed section of the human insert. This distribution of breaks suggests that a
hotspot for break accumulation is present within both FRA3B and FRA7H.
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Table 9. Distribution of 30 breaks within FRA3B insert and break region lengths at each
location.
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Stain
Containing
Broken
FRA3B YAC
Y400
Y401
Y402
Y353
Y404
Y442
Y445
Y441
Y357
Y356
Y403
Y386
Y346
Y398
Y399
Y350
Y344
Y355
Y337
Y339
Y363
Y392
Y351
Y444
Y397
Y387
Y354
Y348
Y340
Y389

Chr 3 base at
centromereproximal end of
break region:
60879994
60837633
60777899
60667292
60656718
60563626
60558353
60558149
60548827
60520497
60493271
60467017
60442468
60442468
60442468
60428334
60425133
60422947
60417177
60416114
60416114
60415288
60411075
60410267
60404781
60404168
60403067
60400567
60395290
60388667

Break Region
size (bp)
5,152
3,419
0
3,786
2,919
1,383
1,513
0
0
798
878
1,143
1,060
1,060
1,060
1,535
795
723
1,063
907
907
0
0
0
1,216
0
659
724
0
0
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Figure	
  23.	
  Distribution	
  of	
  30	
  breaks	
  located	
  within	
  the	
  FRA3B	
  human	
  insert.	
  	
  Yellow	
  
ovals	
  represent	
  break	
  location.	
  	
  Strains	
  contain	
  the	
  portion	
  of	
  the	
  DNA	
  insert	
  that	
  is	
  
centromere	
  proximal	
  to	
  break	
  location.	
  632 kb region of human insert is only portion of
diagram drawn to scale.
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Table 10. Distribution of 30 breaks within FRA7H insert and break region lengths at
each location.
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

Strain
Containing
Broken
FRA7H YAC
Y447
Y467
Y466
Y462
Y457
Y461
Y468
Y452
Y463
Y478
Y471
Y472
Y451
Y459
Y474
Y469
Y476
Y449
Y455
Y473
Y446
Y448
Y453
Y454
Y475
Y450
Y465
Y477
Y470
Y464

Chr7 base at
centromereproximal end of
break region:
130679098
130679098
130671508
130661953
130661597
130647825
130647825
130632701
130629196
130629196
130622056
130621724
130615174
130615174
130615174
130611867
130611867
130608925
130603915
130603106
130594214
130590562
130587907
130587907
130587907
130537901
130537901
130537901
130520657
130426578

	
  

Break Region
Size (bp)
3,714
3,714
0
3,764
0
3,975
3,975
3,505
3,505
3,505
4,038
0
3,307
3,307
3,307
2,942
2,942
3,863
0
0
3,652
2,655
3,806
3,806
3,806
4,477
4,477
4,477
0
3,562
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Figure 24. Distribution of 30 breaks located within the FRA7H human insert. Yellow
ovals represent break location. Strains contain the portion of the DNA insert that is
centromere proximal to break location. 288 kb region of human insert is only portion
of diagram drawn to scale.

3.3 Analysis of Break Distributions in FRA3B and FRA7H
A) Identification and Use of a Critical Break Area.
DNA is resected at a break prior to repair. This resection allows the repair
mechanism to find a sequence with an area of homology within the genome to invade and
copy from. Due to this resection, the break regions identified, and locations at which a
telomere has been added, may not represent the sites at which double-strand breaks occurred
in the YAC. Resection at a break of up to 4 kb before telomere addition has been observed in
an exo1Δ sgs1Δ pif1-m2 mutant yeast strain (Chung et al., 2010). Therefore, I added 4 kb of
sequence to the centromere-distal side of each break region to account for this potential
resection. The area which consists of the experimentally identified break region plus an
added 4 kb was named a critical break area (CBA). Each CBA represents the segment of
DNA in which the break could have occurred (Figure 23). Locations and sizes of critical
break areas for FRA3B are displayed in Table 10. Locations and sizes of critical break areas
for FRA7H are displayed in Table 11. The average critical break area was 5,090±1,238 bp
for the 30 FRA3B broken strains and 6,936±1,549 bp for the 30 FRA7H broken strains.
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Figure 25. Visual display of a critical break area. Critical break areas are segments of
human insert DNA in which the double-stranded break could have occurred. The critical
break area consists of the region between the last primer set to produce a product and
first primer set with no product, plus an additional 4 kb centromere-distal, due to the
possible resection of DNA from break locations.
Table 11. Identification of CBA length and location within broken FRA3B YAC
strains.

	
  

Broken
FRA3B strain
name
Y400
Y401
Y402

Critical Break
Area size (bp)
9152
7419
4000

Location of CBA on
human Chr3:
60879994-60870843
60837633-60830215
60777899-60773900

Y353
Y404
Y442
Y445
Y441
Y357
Y356
Y403
Y386
Y346
Y398
Y399

7786
6919
5383
5513
4000
4000
4798
4878
5143
5060
5060
5060

60667292-60659507
60656718-60649800
60563626-60558244
60558353-60552841
60558149-60649800
60548827-60544828
60520497-60515700
60493271-60488394
60467017-60461875
60442468-60437409
60442468-60437409
60442468-60437409
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Y350
Y344
Y355
Y337
Y339
Y363
Y392
Y351
Y444
Y397
Y387
Y354
Y348
Y340
Y389

5535
4795
4723
5063
4907
4907
4000
4000
4000
5216
4000
4659
4724
4000
4000

60428334-60422800
60425133-60420339
60422947-60418225
60417177-60412115
60416114-60411208
60416114-60411208
60415288-60411289
60411075-60407076
60410267-60406268
60404781-60399566
60404168-60400169
60403067-60398409
60400567-60395844
60395290-60391291
60388667-60384668

Table 12. Identification of CBA length and location within chromosome 7 of broken
FRA7H YAC strains.
	
  

	
  

Broken
FRA7H strain
name

Critical Break
Area size (bp)

Location of Break
on human Chr7:

Y447
Y467
Y466
Y462
Y457
Y461
Y468
Y452
Y463
Y478
Y471
Y472
Y451
Y459
Y474
Y469
Y476
Y449

7714
7714
4000
7764
4000
7975
7975
7505
7505
7505
8038
4000
7307
7307
7307
6942
6942
7863

130679098-130671385
130679098-130671385
130671508-130667509
130661953-130654190
130661597-130657598
130647825-130639851
130647825-130639851
130632701-130625197
130629196-130621692
130629196-130621692
130622056-130614019
130621724-130617725
130615174-130607868
130615174-130607868
130615174-130607868
130611867-130604926
130611867-130604926
130608925-130601063
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Y455
Y473
Y446
Y448
Y453
Y454
Y475
Y450
Y465
Y477
Y470
Y464

4000
4000
7652
6655
7806
7806
7806
8477
8477
8477
4000
7562

130603915-130599916
130603106-130599107
130594214-130586563
130590562-130583908
130587907-130580102
130587907-130580102
130587907-130580102
130537901-130529425
130537901-130529425
130537901-130529425
130520657-130516658
130426578-130419017

B) Analysis of Fragile Site Break Distribution Compared to Distal Flexibility
Peaks.
It has been hypothesized that breaks within common fragile site regions result from
replication fork stalling and collapse at secondary structures in AT-rich ”flexibility peaks”.
These secondary structures may form by intra-strand complementary base pairing when long
segments of single-stranded DNA exist at replication forks due to replication stress. To test
this hypothesis, I compared the distribution of CBAs for each fragile site with the distribution
of AT-rich flexibility peaks in that fragile site. Using the Twistflex program (Mishmar et al.,
1998), I identified 18 flexibility peaks within the 632 kb FRA3B insert (Table 13) and 7
flexibility peaks within the 288 kb FRA7H insert (Table 14). Peaks were categorized as
exceeding the program standard torsion angle of 13.7°, or as exceeding the torsion angles of
14° and 16°. The distribution of CBAs within the fragile site regions compared to flexibility
peak locations is shown in Figure 26 for FRA3B and Figure 27 for FRA7H.
To compare the distribution of CBAs with the locations of flexibility peaks in each
fragile site, I determined the distance from each critical break area to the nearest distal
flexibility peak. Three FRA3B broken strains and one FRA7H broken strain had CBAs
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located centromere-distal to all flexibility peaks. These broken strains were omitted from the
flexibility peak analysis. Flexibility peaks differ in size, and the location of each peak was set
as the base pair at the centromere-proximal end of the flexibility peak. This would be the
location that is closest to the break location (Table 13, FRA3B and Table 14, FRA7H). For
each fragile site, I determined the average distance from CBAs to the nearest distal flexibility
peaks. Using a random number generator, I created 100 sets of 30 matched, control nonbreak areas for each fragile site. I determined the average distance from non-break areas to
the nearest distal flexibility peak for each set. Using the average distances created by the 100
control sets for each fragile site, I developed frequency distributions for FRA3B (Figure 28)
and for FRA7H (Figure 29). The black arrow signifies the experimental average distance to
distal flexibility peaks compared to the frequency distributions of the control sets.
The average distance from critical break areas to distal flexibility peaks within the
FRA3B fragile site insert is significantly smaller than expected from the distribution of
control non-break areas (p>0.01). These data indicate that there is less than 1% chance that
the distribution of breaks within the FRA3B insert was randomly located close to flexibility
peaks. The average distance from the 30 CBAs to distal flexibility peaks was 13,165 bp.
The average distance from the 100 control sets was more than double, at 28,763 bp. In
FRA3B, the majority of breaks are located at the distal end of the insert, close to several
highly flexible regions (Figure 26).
However, the average distance from critical break areas to distal flexibility peaks
within the FRA7H fragile site insert is significantly larger than expected from the distribution
of control non-break areas (P>0.01). These data suggest that there is less than 1% chance
that the distribution of breaks within the FRA7H insert was randomly located far from
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flexibility peaks. The average distance from the 30 CBAs to known distal flexibility peaks
was 32,948 bp. The average distance to distal flexibility peaks for all 100 control sets was
20,664 bp. Breaks within the FRA7H tend to be located distal to the first set of three
flexibility peaks, and very far proximal to the peaks located at the distal end of the insert
(Figure 27). This evidence suggests that FRA3B and FRA7H breaks could be due to
different mechanisms.
Table 13. Flexibility peaks within the 632 kb of FRA3B human insert (chr3: 61,016,76660,384,099).
Peak

	
  

Peak Location on
human
Chromosome 3

Peak Sequence

1

61000645-61000444

2

60941382-60941192

3

60846986-60845685

caagatgagagaaaagaggatcttttaaaatgtcatatatatggat
gtgtgtgtacacatatatatatgtatatggatgtatgtatagatatac
acatatatacatgcatatatatacatatatatacatatataaggatgt
gtatacatatatatatatatatatttttttttttttttttttttttttttttgagg
caga
tatccattcatgttttccttgcttttcttttatcattttgaaataaatttgtc
acatgtatatatgtgtgtgtgtgtatatatatatatatatatatatatat
atatatatatgtatatatatgcctaagcagatacattttagtttttaagt
attataaaatggttttataatggtttaatctctggaaa
cgtcaaaacccagtagcttaactgaaaaaaaaaagaaagatata
tgatatgatatatcatatgtatcatatatgatatgatatatcatatatat
catatatatcatatatatcatatatgatatatatcatatatatcataga
acatatgatatatatgtatatagatcatatatacatatatcatatatac
acatataggatatatgtgtatatatgatatctgatatatatgacgtac
atcatatatacacatgatatatatgacgtacgtcatatatacatgata
tacgtatatatgtatcatatatatggatatatacgtatatatgtatcat
atatacatgatatatacgtatatatgtatcatatatacatgatatatac
gtatatatgtatcatatatacatgatatatacgtatatatgttcatatat
acatgatatatatgtacatatgttcatatatacctgatatatgtacata
tgtatcatatatacctgatatatatgtacatatgtatcatatatacctg
atatatgatacatatgtatcatatatacctgatatatatgaacatatgt
acatatatacctgatatatatgtacatatgtacatatatacctgatat
atatgtacatatgtacatatatacctgatatatgtacatatgtatcata
tatacctgatatatatgtacatatgtatcatatatacctgatatatgat
acatatgtatcatatatacctgatatatgatacatatgtatcatatata
cctgatatatatgatacatatgtatcatatatacctgatatatatgata

Minimum
Torsion
Angle for
identification
16o

14o

16o
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4

60774935-60774792

5

60774280-60774123

6

60758155-60757973

7

60750604-60750421

8

60663451-60663206

9

60593599-60593448

10

60581414-60581160

catatgtatcatatatacatatatatgtacatatgtatcatatatacat
gatatatatgtatcatatatacatatgatgtatgtcatatatacatatg
atgtatgtcatgtatacatatgatgtatgtcatgtatacatatgatgta
tctcatgtatacatatgatgtatctcatgtatacatatgatgtatctca
tgtatacatatgatgtatctcatgtatacatatgatgtatctcatgtat
accatatatacatatgatgtatctcatgtataccatatatacatatga
tgtatctcatgtataccatatatacatatgatgtatatcatatatacca
tatgtatatatatcagatatatcatttatatatcatatatcagatatatc
atatatatatcatatatcagatatatcatatatatgtatctttttgttttttt
gagatgtagtcccacttcttcaccaggctg
tgtctctctctctctctctctctctctatatatatatatatatatacacac
acacacacatctctctctatatatacatatctatatatacatatagat
attcaactctcatctctctctctatatatgtatatattttttttc
ggtgtataacaccaaaatggttaaaaactactaaacatacatatat
acacatgtgcatgtatacacacaaatatgtaaaatatatatacacat
atacattctatgtatatatatagttgatcctgatttttcataggaaattg
ttgtataaagtctcc
cttggtattcgtattctggttagtgactttacctactcagattttgatta
tgcctctatgatgtcaaatatatatatatatatatatatatatatatata
tatatatagatgagaagtgaacaatctacttaatctatcatctggat
gtttcatttctatctcagtgataatctggatgcttc
tttttggtttcaggttaagaatatgatcttgaaatatatatattcatata
ttgacatgtcatttatataacattatatatttgtacatttattatatattaa
ttatatgtaattatatgttgtatattaacacatattaatatatctataatc
tcatcctagttttttcttaatcaataccccc
aaaaaatcaagatgattaaataaagaaaatgtgctctgtgtgtgta
tataagtgtatacatatgtatatatatacacacacacatacacatat
acatatgtatacacatatatacacacacaccacatgtatatacatat
acacatatatacatacagcacattttatttatgtatatgtgtgtgtata
tatgtatacataatagaatactattcagccacagaaaatgaatgaa
aacatgtcttt
cacagcaagccaagtttctggcctacttctcaagaatatgaatata
tatacatatatgtttatatgtgtgtatatatgtatatgtgtgtatatatgt
atatgtatgtattgcagacaaaagttttcctaaattagtgaaattagt
acaaaat
gacacctagtctcttaaaatacacacatacacacactatacacac
acacacacatatatacatacacacatatatctacacgtatatacac
atacgtatgtgcgtatatatatatacacatatgtccatatatacacac
acatatatatgtgtgtgtgtccatatatatatacacacacacacatat
atacatatttatatgtatatgtatatatttaggacagaaatgcttggtg
atcctccatgttctttccc

14o
14o

14o

14o

14o

14o

14o
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11

60578074-60577853

12

60565421-60565238

13

60555495-60555384

14

60539278-60539144

15

60436194-60436039

16

60427593-60427370

17

60404221-60403995

18

60401739-60401538

ttattcgcatctcctttagtattctcagtaaattatcatggtgtatctat
gattttatatatatatatatatagagagagagtatatatagtatatata
tggaatatatatagtatatatatatatagaggttacatatagagaata
tatagagagataatatatatataataatatatatattctacctaattttg
atacaatgtggagttcaaaatgtct
actgtagtaatagtttagctaatgtaagacagactgtaatttataag
catgtatatatttatatgtgtgtgtatatataggtatatatgtgtatatg
tatagacatgtgtttatatattcacatagtgttattttaaccatactcat
gttaagcattatagtttgtcaacatacatattaactt
aaaaaaatatatatatatatatatatatatatatatagtattaataaata
aatatctctaaatatgaggtgactaatttgggaagtactgccattga
gtataaatggggaaa
tctctctctccctctctctctctctatatatatatatatatatttttttaaat
atatataatttttatatataaaataaatataaaatatatatatatatatat
tttaaagcagtgacctctttttgcataaaag
atacagttctatacaggacctggataatatgcacagctcagctctt
agagatatatatacatatttatatcttggggatatatacacatatatat
atatttatgtaccataaaacatttcagtcaacagtgaaccacatata
tgacagtggcccca
aaaaacacaactaaaaaaagaatgagcgggaggaaaaatgac
ctgatatatatatatatatatatatatatatatatttttatacatataaat
atatatatatttttatatatataaatatatatatataaatacaaatatata
tatatatatatataaatacctacagatgcatcaaatatcaattcttca
agaatgtattggcctaagatttacaacaactt
aaaagcaagaaaaataccttggtaagggctgtctaatcgtctgtg
gtgtgtgtgtatacacgtatatatatatatatatatatatatatatatat
atatatatatatatatacacacattcagatacatatatataggtttgta
tatgtattaatatttaatgtatgaatatagcatgacataattatgtaaa
attaatgttaatacatatttttaaaactaaaaat

14o

tggtaggtactatgccaaatgattcaaaaatatgtaagctattatat
ataatatattttacactataattataattaatggaattaatatgttatat
ataattatattgtatgtaataataatatataatagtattatataataata
tcttatataaaaatcccaaagtaattattattattttatagatgaggaa
agtgag

14o

14o

14o

14o
14o

16o

16o
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Table 14. Flexibility peaks within the 288 kb of FRA7H human insert (chr7: 130,412,430130,700,765).

Peak

Peak Location on
human
Chromosome 7

Peak Sequence

1

130650518-130650409

2

130633473-130633329

3

130617500-130617386

4

130531267-130531019

tagttattattttatgctttatataattattagtattgcaacacaat
taaaatatatatttcatttggatatgtaatattacatataggata
catgatatgaaataagtt
tttctttctttctttcatatatttatagatgaaatatatatatatatat
atacacagataagactatatctatatgtaaatacagatactta
aaatatatatgtatatattttaatcgtggtaaaatatgtaacag
aaaaattac
tagccttcacgatatatatgaatatatcataatgtgtgtatcta
gtgtgtgaatatatatcataacttatccactttatggatatcata
atttatccattttagtgattccagga
cacaatcaagagccagttccttaaaataaatctctctatatat
gtgtatatatatatttctatatatacacacacatatgtatatattt
atacacatacctatctgcatacatgcatgtatacacataggta
tatctatatacacacgtacacatatatatgtgtataaatatatat
atatatatatacacatataattatgtatgtccgattctgtttctca
ggagaaccccaacacagtgactaagg

5

130497525-130497329

6

130495285-130495123

7

130449273-130449105

aacccccatggcacatgtatacctatgtaacacacctgcgc
gttctgcacatgtatcccagatcttaaagtatatatatatatata
tatatatatatatatatatatatatatatatatatatatatatatata
aatactaggtagcaacaaaagaaaagtcatgtaaaacatga
gacttgaaatagaaaaaaaaag
ctccctacttatatttttagatgctatttatatatttatattgaatat
acttatgttttatatattgatataatttgacatatgcagatatgg
catatatatgtgctattacatctatgtacattataaaaccaaca
ataaagtgttataattattgctttaa
aaactgcatgttctgcacatgtaacccagaatttaaagtatat
ataaatgtgtttgtgtgtgtgtatatatatatatatgtgtgtgtgt
gcatatatatatatatatagcaccgtactggcataaatacaca
cacatagaccagtgaaacagaatagagaatgcagaag

Minimum
Torsion
Angle for
identification
13.7o
14o

13.7o
14o

16o

14o

14o
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Figure 26. Break distribution compared to flexibility peak location within FRA3B insert.
Red arrows show locations of flexibility peaks. The height of each flexibility peak
correlates to the torsion angle at which it was identified. Break locations are shown as
yellow ovals. Strains still contain intact YAC that is centromere proximal to the break
location.

	
  

	
  	
  	
  	
  	
  	
  	
  	
  	
  

	
  

Figure 27. Break distribution compared to flexibility peak location within FRA7H insert.
Red arrows show locations of flexibility peaks. The height of each flexibility peak
correlates to the torsion angle at which it was identified. Break locations are shown as
yellow ovals. Strains still contain intact YAC that is centromere proximal to the break
location.
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Figure 28. Frequency distribution of the average distance from non-break areas to distal
flexibility peaks within the FRA3B insert. Distribution consists of 100 control sets, each
with 27 matched, non-break areas. The black arrow shows average distance from
experimental critical break areas to distal flexibility peaks. The average distance for the
experimental test was 13,165 bp, which is significantly smaller than control non-break
average distances (p<0.01).
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Figure 29. Frequency distribution of the average distance from non-break areas to distal
flexibility peaks within the FRA7H insert. Distribution consists of 100 control sets, each
with 27 matched, non-break areas. The black arrow shows average distance from
experimental critical break areas to distal flexibility peaks. The average distance for the
experimental test was 32,948 bp, which is significantly larger than control non-break
average distances (p<0.01).
	
  
C) Analysis of Flexibility Peaks by Standard Initiation Duplex Destabilization
(SIDD) 	
  
Flexibility peaks have been suggested to fold into secondary structures within singlestranded DNA at the replication fork. However, spontaneous denaturation of DNA would
also provide single-stranded regions that permit structure formation. I used the WebSIDD
server (http://benham.genomecenter.ucdavis.edu/sibz/) to calculate the statistical mechanical
equilibrium properties of the strand separation transition in a DNA sequence that was under
negative superhelical stress (Bi and Benham, 2004). I determined the amount of free energy
needed to spontaneously denature the two strands of the DNA molecule. This analysis was
completed using the sequence of FRA3B and FRA7H flexibility peaks identified through the
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Twistflex program (Mishmar et al., 1998) flanked by 500 bp on either end. A representation
of the SIDD output free energy G(x) plot along with the probability P(x) plot using FRA3B
flexibility peak 17 is shown in Figure 30.
I identified the minimum G(x) value determined from the G(x) plot for each
flexibility peak. The results from the SIDD analysis for FRA3B and FRA7H flexibility
peaks is shown in Table 15.
The experimental analysis showed that the average minimum G(x) of the FRA3B
flexibility peaks was 1.9421±1.1681. This was compared to the FRA7H flexibility peaks
with an average minimum G(x) of 2.6446±1.4902. A Mann-Whitney U Test/Wilcoxon Rank
Sum Test determined that where was no difference between the minimum free energies
(G(x)) of the two sets of flexibility peaks ( P, two-tailed test=0.326078). This information
suggests that the DNA’s susceptibility to random denaturation due to spontaneous free
energy does not differ between FRA3B and FRA7H flexibility peaks and therefore does not
help to determine the reason for breaks occurring close to flexibility peaks in the FRA3B
fragile site, but far from flexibility peaks in the FRA7H fragile site.
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Figure
30. Representation of SIDD free energy (G(x)) and Probability (P(x)) plots
	
  
used in determining lowest free energy flexibility peaks. The free energy G(x) plot
identifies
the minimum free energy within the analyzable region. The P(x)
	
  
probability plot shows the likelihood of a denaturation event occurring.
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Table 15. SIDD results of FRA3B and FRA7H flexibility peaks.
	
  
FRA3B flexibility Peak location on human
Peak
chromosome 3 flanked by 500 bp
1
60999944-61001145
2
60940692-60941882
3
60845185-60847486
4
60774292-60775435
5
60773623-60774680
6
60757473-60758655
7
60749921-60751104
8
60662706-60663951
9
60592948-60594099
10
60580660-60581914
11
60577353-60578574
12
60564738-60565921
13
60554884-60555995
14
60538644-60539778
15
60435539-60436694
16
60426870-60428093
17
60403495-60404721
18
60401038-60402239
FRA7H flexibility peak location on human
chromosome 7 flanked by 500 bp
Peak
1
130649909-130651018
2
130632829-130633973
3
130616886-130618000
4
130530519-130531767
130496829-130498025
5
6
130494623-130495785
7
130448605-130449773

Min G(x)
0.5648
1.0494
1.2580
2.6455
2.9698
0.7165
2.4354
2.8632
4.2830
3.2598
1.5210
3.7605
1.0939
0.8144
2.2035
0.8653
0.5485
2.1058

Min G(x)
4.1726
2.9718
2.5661
0.6802
0.5570
3.5956
3.9689

	
  
	
  
	
  
	
  

	
  

94	
  

D) Analysis of	
  the	
  Potential	
  For	
  Secondary	
  Structure	
  Formation	
  in	
  Critical	
  
Break	
  Areas	
  	
  
The first hypothesis suggests that during replication stress, secondary structure
formation can lead to fork progression and stalling leading to eventual breakage. Although
these structures have been proposed to form at flexibility peaks, other sequences in fragile
site regions may also have the potential for secondary structure formation. To evaluate this
potential, I performed an mFOLD analysis to determine stable secondary structure formation
of DNA when single stranded. The mFOLD Web Server
(http://mfold.rna.albany.edu/?q=mfold/DNA-Folding-Form) accepts sequence of interest and
determines the free energy associated with each secondary structure that could be
constructed, assuming the segment of DNA was single stranded. This analysis allows me to
determine whether stable secondary structures could form in regions of the DNA in which
breaks had been identified. An mFOLD analysis was completed on the 30 CBAs for both
FRA3B and FRA7H, as well as on a set of 30 control non-break areas for each fragile site. A
representative example is presented for the most stable secondary structure predicted by
mFOLD from single stranded DNA within the critical break area for broken FRA7H YAC
Y455 (Figure 31).
The most stable predicted secondary structure (with the lowest free energy) was
identified for each CBA, and for each matched non-break area (Tables 16 and 17). The
average low free energy of the CBAs for the FRA3B insert was −89.33±16.20 kcal/mol, and
non-break areas in FRA3B have an average low free energy of −91.48±23.36 kcal/mol
(Table 16). The comparison between the two data sets shows no difference between the
average low free energy of areas in which breaks had been identified and those where breaks
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had not occurred. The average low free energy of the CBAs for the FRA7H insert was
−109.45±28.23 kcal/mol, and non-break areas within the FRA7H insert have an average low
free energy of −114.76±48.76 kcal/mol (Table 17). Again, the comparison between critical
break and non-break areas showed no difference in average low free energy.
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Figure 31. Representative mFOLD analysis results. The most stable secondary structure
formation of a strand of single stranded DNA from the critical break area in broken strain
Y455 is shown. The free energy of this structure is -90.11 kcal/mol.	
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Table 16. mFOLD results of 30 critical break areas and 30 non-break areas within the
FRA3B human insert region.
	
  

	
  

Broken FRA3B
strain
Y337
Y339
Y340
Y344
Y346
Y348
Y350
Y351

Critical Break
Area (bp)
5063
4907
4000
4795
5060
4724
5535
4000

Location of CBA on
human Chr3:
60417177-60412115
60416114-60411208
60395290-60391291
60425133-60420339
60442468-60437409
60400567-60395844
60428334-60422800
60411075-60407076

Y353
Y354
Y355
Y356
Y357
Y363
Y386
Y387
Y389
Y392
Y397
Y398
Y399
Y400
Y401
Y402
Y403
Y404
Y441
Y442
Y444
Y445

7786
4659
4723
4798
4000
4907
5143
4000
4000
4000
5216
5060
5060
9,152
7,419
4000
4878
6,919
4000
5383
4000
5513

60667292-60659507
60403067-60398409
60422947-60418225
60520497-60515700
60548827-60544828
60416114-60411208
60467017-60461875
60404168-60400169
60388667-60384668
60415288-60411289
60404781-60399566
60442468-60437409
60442468-60437409
60879994-60870843
60837633-60830215
60777899-60773900
60493271-60488394
60656718-60649800
60558149-60649800
60563626-60558244
60410267-60406268
60558353-60552841

	
  
	
  

Free Energy
(kcal/mol)
-87.72
-91.34
-77.42
-81.29
-88.29
-81.48
-92.13
-88.70
-166.30
-85.48
-75.23
-90.46
-91.33
-91.34
-99.93
-91.80
-90.85
-72.38
-88.40
-88.29
-88.29
-91.83
-81.48
-82.71
-75.49
-102.08
-73.72
-93.25
-82.64
-88.19
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Control FRA3B
Strain
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
C26
C27

Non-Break Area
(bp)
5063
4907
4000
4795
5060
4724
5535
4000
7786
4659
4723
4798
4000
4907
5143
4000
4000
4000
5216
5060
5060
9,152
7,419
4000
4878
6,919
4000

Location of NBA on
human Chr3:
60569910-60569111
60602508-60601709
60547155-60546356
60981352-60980553
60826519-60825720
60796748-60795949
60455910-60455111
60491626-60490827
60647367-60646568
60993291-60992492
60888142-60887343
60914634-60913835
60563633-60562834
60586935-60586136
60810454-60809655
60579306-60578507
60405011-60404212
60426951-60426152
60714710-60713911
60886977-60886178
60831124-60830325
60638235-60637436
60641103-60640304
60825036-60824237
60778264-60777465
60946905-60946106
60779199-60778400

Free Energy
(kcal/mol)

C28
C29
C30

5383
4000
5513

60675657-60674858
60632531-60631732
60532669-60531870

-79.78
-82.40
-73.14

-80.84
-157.40
-89.52
-102.52
-83.53
-84.38
-157.40
-86.14
-‐79.82	
  
-‐84.45

-72.70
-‐108.55	
  
-‐93.35

-79.65
-88.43
-80.84
-89.36
-82.89
-88.17
-77.83
-84.90
-96.13
-97.60
-88.16
-79.75
-79.75
-86.71
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Table 17. mFOLD results of 30 critical break areas and 30 non-break areas within the
FRA7H human insert region.
	
  
	
  
Broken FRA7H
strain
Y446
Y447
Y448
Y449
Y450
Y451
Y452
Y453
Y454
Y455
Y457
Y459
Y461
Y462
Y463
Y464
Y465
Y466
Y467
Y468
Y469
Y470
Y471
Y472
Y473
Y474
Y475
Y476
Y477
Y478
Control FRA7H
Strain
C1
C2
	
  

Critical Break
Area (bp)
7652
7714
6655
7863
8477
7307
7505
7806
7806
4000
4000
7307
7975
7764
7505
7562
8477
4000
7714
7975
6942
4000
8038
4000
4000
7307
7806
6942
8477
7505
Non-Break Area
(bp)
7652
7714

Location of Break on
human Chr7:
130594214-130586563
130679098-130671385
130590562-130583908
130608925-130601063
130537901-130529425
130615174-130607868
130632701-130625197
130587907-130580102
130587907-130580102
130603915-130599916
130661597-130657598
130615174-130607868
130647825-130639851
130661953-130654190
130629196-130621692
130426578-130419017
130537901-130529425
130671508-130667509
130679098-130671385
130647825-130639851
130611867-130604926
130520657-130516658
130622056-130614019
130621724-130617725
130603106-130599107
130615174-130607868
130587907-130580102
130611867-130604926
130537901-130529425
130629196-130621692
Location of NBA on
human Chr7:
130684351-130676700
130455908-130448195

Free Energy
(kcal/mol)
-102.67
-204.41
-101.74
-99.72
-100.99
-109.91
-97.61
-127.46
-127.46
-90.11
-108.79
-109.91
-99.97
-116.65
-85.96
-102.59
-100.99
-86.91
-204.41
-99.97
-106.50
-96.96
-93.06
-87.83
-89.96
-109.91
-127.46
-106.50
-100.99
-85.96
Free Energy
(kcal/mol)
-99.18
-83.31
100	
  

C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
C26
C27
C28
C29
C30

6655
7863
8477
7307
7505
7806
7806
4000
4000
7307
7975
7764
7505
7562
8477
4000
7714
7975
6942
4000
8038
4000
4000
7307
7806
6942
8477
7505

130584520-130577866
130675281-130667419
130667787-130659311
130523437-130516131
130468633-130461129
130574803-130566998
130677521-130669716
130444789-130440790
130536962-130532963
130698894-130691588
130465607-130457633
130495801-130488038
130602901-130595702
130449319-130441758
130639056-130630580
130501219-130497220
130487926-130480213
130618025-130610051
130696530-130689589
130482558-130478559
130490255-130482218
130478894-130474895
130414024-130410025
130502129-130494823
130586623-130578818
130674661-130667720
130539981-130531505
130622904-130615400

-115.85
-255.76
-115.66
-114.36
-115.17
-212.30
-225.42
-103.19
-88.33
-91.97
-114.40
-99.80
-93.68
-88.12
-91.50
-85.71
-117.75
-102.12
-93.54
-77.60
-118.01
-88.37
-68.14
-93.33
-123.49
-81.34
-90.69
-88.89
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E) Analysis of Fragile Site Break Distribution Compared to Potential Origins.
The second hypothesis suggests that breaks within fragile regions result from the
inability of replication to complete before mitosis, due to the lack of origin sites available to
fire when cells are under replication stress. This would result in breaks at regions of unreplicated DNA during anaphase. To test this hypothesis, I analyzed the break distribution
within the fragile site inserts compared to locations of potential yeast origins. I determined
potential yeast origins by the identification of an 11 bp autonomous consensus sequence
followed by 100 bp of AT-richness of greater than 67 percent at the 3’ end of the sequence.
The 23 potential yeast origins used in comparison to FRA3B critical break areas are
identified in Table 18. The 15 potential yeast origins used in comparison to FRA7H critical
break areas are shown in Table 19. The distribution of potential yeast origins compared to
experimental breaks, within the FRA3B region, is shown in Figure 32 and, within the
FRA7H region, is shown in Figure 33.
For the analysis, I determined the distance from each CBA to the nearest potential
yeast origin. Origins both centromere-proximal and centromere-distal to the CBA were
considered, because replication from either direction would be sufficient to copy the region.
For each fragile site, I determined the average distance from CBAs to the nearest potential
yeast origin. Using a random number generator, I created 100 sets of 30 matched, control
non-break areas for each fragile site. I determined the average distance from non-break areas
to the nearest potential yeast origin for each set. Using the average distances created by the
100 control sets for each fragile site, I developed frequency distributions displayed in Figure
34 for FRA3B and Figure 35 for FRA7H. The black arrow signifies the experimental
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average distance to potential yeast origins compared to the frequency distributions of the
control sets.
The average distance from critical break areas to potential yeast origins within the
FRA3B fragile site insert was significantly larger than expected from the distribution of
control non-break areas (p>0.01). In FRA3B, the average distance from CBAs to the closet
potential origin was 43,604 bp. The average distance for all 100 control sets combined was
16,586 bp. The average distance from critical break areas to potential yeast origins within
the FRA7H fragile site insert was also significantly larger than expected (P>0.01). In
FRA7H, the average distance from CBAs to the closet potential origin was 12,907 bp. The
average distance for all 100 control sets combined was 8,695 bp. Therefore, breaks within
both FRA3B and FRA7H occur within regions that are significantly far away from potential
origins. Figures 32 and 33 both show breaks accumulate in locations where potential origins
are not present.
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Table 18. Potential origins within the 632 Kb of FRA3B human insert (chr3: 6101676660384099).
Potential Origin
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23

Location along
human
chromosome 3
61012694
60998354
60956029
60952747
60936805
60871182
60868805
60828183
60803001
60702105
60688547
60688237
60677765
60671627
60658438
60594685
60588940
60568921
60514974
60513437
60499197
60497287
60483165

AT-richness of B
domain
69%
85%
75%
69%
67%
72%
71%
80%
67%
75%
74%
80%
67%
74%
72%
74%
69%
67%
72%
68%
73%
76%
74%

	
  

	
  
Figure 32. Break distribution compared to potential origin location within FRA3B insert.
Gray ovals show location of potential origins. Break locations are shown as yellow ovals
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Table 19. Potential origins within the 288 Kb of FRA7H human insert (chr7: 130700765130412430).
	
  
Potential Origin
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Location along
human
chromosome 7
130663755
130631346
130630771
130560369
130559783
130512402
130511354
130503779
130461793
130461312
130454328
130453665
130443867
130433997
130427671

AT-richness of B
domain
67%
76%
71%
68%
67%
73%
75%
73%
73%
69%
73%
68%
78%
71%
69%

	
  

	
  

	
  
Figure 33. Break distribution compared to potential origin location within FRA7H insert.
Gray ovals show location of potential origins. Break locations are shown as yellow ovals.
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Figure 34. Frequency distribution of the average distance from non-break areas to
potential yeast origins within the FRA3B insert. Distribution consists of 100 control sets,
each with 30 matched, non-break areas. Black arrow shows average distance from
experimental critical break areas to potential yeast origins. The average distance for the
experimental test was 43,604 bp, which is significantly larger than control non-break
average distances (p<0.01).
	
  

	
  
	
  

	
  

106	
  

	
  

	
  	
  
Figure 35. Frequency distribution of the average distance from non-break areas to
potential yeast origins within the FRA7H insert. Distribution consists of 100 control sets,
each with 30 matched, non-break areas. Black arrow shows average distance from
experimental critical break areas to potential yeast origins. The average distance for the
experimental test was 12,907 bp, which is significantly larger than control non-break
average distances (p<0.01).
	
  
F) Analysis of GT-Richness of Critical Break Areas.
Telomere addition preferentially occurs at GT rich “seed” sequences (Kramer and

Haber, 1993). The telomere seed sequence may be identified by repair mechanisms after
resection of DNA from a double-stranded break. Although exo1Δ sgs1Δ pif1-m2 mutant
yeast strains have a reduction in this preference (Chung et al., 2010), it is possible that CBA
location is due to sequence content that promotes telomere addition rather than to fragile site
instability at that location. To evaluate this possibility, I calculated the GT-richness of 30
broken YAC strains for both FRA3B and FRA7H, as well as a sample of 30 control nonbreak areas for each fragile site. The non-break areas for the FRA3B fragile site had no
location overlap with the 30 CBAs. The non-break areas for the FRA7H fragile site had
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approximately 30% location overlap with the CBAs due to the fact that the smaller size of the
sequence did not allow for selection of non-break areas that did not have partial overlap with
critical break areas.
The average GT richness of the critical break areas for the FRA3B insert is
51.88±1.90%, compared to average GT richness of 52.07±2.00% in control non-break areas
(Table 20). The average GT richness of the critical break areas for FRA7H insert was
51.18±1.86%, compared to average GT richness of 50.31±3.57% in control non-break areas
(Table 21). For each fragile site, I also evaluated the GT-richness of experimental critical
break areas at which telomeres were successfully identified. The average GT-richness for the
critical break areas of 9 FRA3B broken strains with positive telomere addition was
52.02±0.87%. The average GT-richness for the critical break areas for 6 FRA7H broken
strains with positive telomere addition was 51.27±1.84%. Again, the comparison between
critical break and non-break areas showed no difference in average GT-richness.
Comparison between critical break areas of broken strains with positive telomere addition
compared to strains where telomere addition was not identified also showed no difference.
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Table 20. GT richness of 30 critical break areas and 30 non-break areas within the
FRA3B human insert region.
	
  
Broken FRA3B
strain
Y337
Y339
Y340
Y344
Y346
Y348
Y350
Y351
Y353
Y354
Y355
Y356
Y357
Y363
Y386
Y387
Y389
Y392
Y397
Y398
Y399
Y400
Y401
Y402
Y403
Y404
Y441
Y442
Y444
Y445
Control FRA3B
Strain
C1
C2
	
  

Critical Break
Area (bp)
5063
4907
4000
4795
5060
4724
5535
4000
7786
4659
4723
4798
4000
4907
5143
4000
4000
4000
5216
5060
5060
9,152
7,419
4000
4878
6,919
4000
5383
4000
5513
Non-Break Area
(bp)
5063
4907

Location of CBA on
human Chr3:
60417177-60412115
60416114-60411208
60395290-60391291
60425133-60420339
60442468-60437409
60400567-60395844
60428334-60422800
60411075-60407076
60667292-60659507
60403067-60398409
60422947-60418225
60520497-60515700
60548827-60544828
60416114-60411208
60467017-60461875
60404168-60400169
60388667-60384668
60415288-60411289
60404781-60399566
60442468-60437409
60442468-60437409
60879994-60870843
60837633-60830215
60777899-60773900
60493271-60488394
60656718-60649800
60558149-60649800
60563626-60558244
60410267-60406268
60558353-60552841
Location of NBA on
human Chr3:
60868002-60862940
60719145-60714239

% GT content
within CBA
52.29%
53.49%
51.73%
51.44%
53.39%
51.27%
52.01%
52.00%
48.02%
51.88%
48.74%
52.06%
52.15%
53.50%
52.40%
52.25%
51.10%
53.48%
52.36%
53.38%
53.38%
52.41%
52.26%
52.50%
51.17%
44.92%
52.55%
52.89%
50.45%
54.98%
% GT content
within NBA
58.54%
51.50%
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C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
C26
C27
C28
C29
C30

	
  

4000
4795
5060
4724
5535
4000
7786
4659
4723
4798
4000
4907
5143
4000
4000
4000
5216
5060
5060
9,152
7,419
4000
4878
6,919
4000
5383
4000
5513

60570885-60566886
60605610-60600816
60997227-60992168
60943327-60938604
60618838-60613304
60488228-60484229
60859566-60851781
60472496-60467838
60828385-60823663
60931347-60926550
60963909-60959910
60744791-60739885
60448877-60443735
60688192-60684193
60936841-60932842
60850055-60846056
60901962-60896747
60458419-60453360
60810367-60805308
60797282-60788131
60583198-60575780
60761437-60757438
60730033-60725156
60913805-60906887
60890278-60886279
60536758-60531376
60681407-60677408
60642588-60637076

51.63%
52.76%
51.88%
53.32%
49.47%
51.38%
50.95%
60.42%
50.75%
48.52%
50.50%
51.36%
53.80%
49.73%
51.63%
51.48%
52.17%
45.65%
51.34%
50.79%
52.95%
51.43%
51.62%
56.02%
51.83%
51.74%
52.95%
53.95%
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Table 21. GT richness of 30 critical break areas and 30 non-break areas within the
FRA7H human insert region.
	
  

Broken FRA7H
strain
Y446
Y447
Y448
Y449
Y450
Y451
Y452
Y453
Y454
Y455
Y457
Y459
Y461
Y462
Y463
Y464
Y465
Y466
Y467
Y468
Y469
Y470
Y471
Y472
Y473
Y474
Y475
Y476
Y477
Y478
Control FRA7H
Strain
C1
C2
	
  

Critical Break
Area (bp)
7652
7714
6655
7863
8477
7307
7505
7806
7806
4000
4000
7307
7975
7764
7505
7562
8477
4000
7714
7975
6942
4000
8038
4000
4000
7307
7806
6942
8477
7505
Non-Break Area
(bp)
7652
7714

Location of Break on
human Chr7:
130594214-130586563
130679098-130671385
130590562-130583908
130608925-130601063
130537901-130529425
130615174-130607868
130632701-130625197
130587907-130580102
130587907-130580102
130603915-130599916
130661597-130657598
130615174-130607868
130647825-130639851
130661953-130654190
130629196-130621692
130426578-130419017
130537901-130529425
130671508-130667509
130679098-130671385
130647825-130639851
130611867-130604926
130520657-130516658
130622056-130614019
130621724-130617725
130603106-130599107
130615174-130607868
130587907-130580102
130611867-130604926
130537901-130529425
130629196-130621692
Location of NBA on
human Chr7:
130573993-130566342
130464229-130456516

% GT content
within CBA
50.72%
51.34%
50.46%
50.88%
47.71%
52.55%
53.60%
51.04%
51.04%
51.90%
51.10%
52.55%
52.59%
50.26%
53.98%
47.49%
47.71%
53.58%
51.34%
52.59%
51.47%
48.10%
51.85%
52.18%
50.73%
52.55%
51.04%
51.47%
47.71%
53.98%
% GT content
within NBA
50.47%
43.16%
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C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
C26
C27
C28
C29
C30

6655
7863
8477
7307
7505
7806
7806
4000
4000
7307
7975
7764
7505
7562
8477
4000
7714
7975
6942
4000
8038
4000
4000
7307
7806
6942
8477
7505

130669791-130663137
130625442-130617580
130647897-130639421
130697350-130690044
130526115-130518611
130495035-130487230
130565734-130557929
130588485-130584486
130568410-130564411
130424776-130417470
130650485-130642511
130599890-130592127
130454044-130446540
130530285-130522724
130507952-130499476
130608350-130604351
130447949-130440236
130693362-130685388
130479388-130472447
130592709-130588710
130427744-130419707
130663992-130659993
130452350-130448351
130508965-130501659
130422748-130414943
130688771-130681830
130606763-130598287
130462449-130454945

52.58%
53.11%
52.74%
53.11%
48.41%
48.67%
50.56%
51.65%
51.48%
46.61%
51.50%
52.37%
44.86%
46.81%
45.63%
50.65%
46.09%
52.48%
46.67%
49.03%
53.68%
49.60%
60.28%
54.78%
50.51%
48.16%
48.67%
55.10%
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Chapter 4
Discussion
The purpose of this study was to gain understanding of the pathway by which breaks
occur in common fragile site regions of human DNA. In order to evaluate the mechanism for
chromosomal breakage, I first determined where fragile site breaks were occurring. I used a
model system in which segments of human DNA that contained fragile sites FRA3B and
FRA7H were propagated in Saccharomyces cerevisiae using yeast artificial chromosomes. I
induced breakage of the YAC, isolated the products, and used PCR to determine the locations
of double-stranded breaks to a region of less than 6 kb. Breakage events occur throughout the
fragile site regions, but in both FRA3B and FRA7H, the majority of breakage events happen
within a small region of each fragile site. My analysis of these break locations suggests that
the lack of origins available to complete replication plays a role in breakage events within
both FRA3B and FRA7H. The break location analysis also suggests the possibility that
secondary structure formation at AT-rich flexibility peaks could contribute to breakage
within the common fragile site FRA3B but is unlikely to contribute to breakage within
common fragile site FRA7H.
I identified 30 strains containing a break in FRA3B and 30 strains containing a break
in FRA7H. Starting with a working area of 632 kb for the FRA3B insert and 288 kb for the
FRA7H insert, I narrowed each break location to a region of 6 kb or less. Rajula (2011) used
this method to identify break locations within the FRA3B fragile site region, but the majority
of her identified break regions contained a larger segment of DNA at which a break could
have occurred. By narrowing break locations, I was able to determine a definitive breakage
distribution within the FRA3B and FRA7H inserts (Figures 23 and 24).
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I also used telomere PCR to determine the exact location at which yeast telomere
DNA capped human broken DNA in nine strains containing broken FRA3B YACs and six
strains containing broken FRA7H YACs. This analysis did not identify an exact break
location. Even within the mutant yeast strain used, resection from a double-stranded break
could still occur up to 4 kb (Chung et al., 2010). The telomere identification reduced the
critical break area for which a break could be located. I was not able to positively identify
telomere addition at all fragile site break locations. The method of identifying telomere
addition involved PCR between a human DNA forward primer and a yeast DNA reverse
primer. The reagents used in the PCR reaction give positive banding up to approximately
1500 bp. Since the majority of my CBAs were larger than 1500 bp, broken strains could
contain yeast telomeres and not be identified. Chung et al, 2010 suggest that break-induced
replication (BIR) could also result as a mechanism for repair after a double-stranded break. I
could find break locations by identifying a loss of a distal end of the YAC human insert, but
under the current assay, I would not be able to identify addition of DNA that has been used to
repair the double-stranded break from a region of homology in the yeast genome.
Previously, common fragile site FRA3B was reported to span from exon 3 to midway
through intron 5 of the FHIT gene (chr3: 61,016,766-60,384,099)(Durkin et al., 2008).
Zimonjic et al., (1997) identified the majority of breakage events between exon 4 and
midway into inton 5 of the FHIT gene (60,807,691-60,392,054) with a very low percentage
falling centromere-proximal to that location. Rajula (2011) identified breaks within FRA3B
exclusively within intron 5 (60,511,503-60,392,054) and suggested that the fragility of
FRA3B could be narrowed to within this region. My results suggest that breakage events
occur in a similar pattern to the breakage distributions developed by Durkin et al. (2008) and
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Zimonjic et al., (1997); breaks occur on chromosome 3 from 60,879,994-60,388,667 (Figure
23). This evidence suggests that the size of the break region of FRA3B is smaller than
reported by Durkin et al., (2008) and Zimonjic et al., (1997) but substantially larger than
reported by Rajula (2011). The breakage analysis for Durkin et al., (2008) used a sample size
of 11 human-mouse hybrid cells, Rajula (2011) used a sample size of 23 yeast strains with
broken YACs and I used a sample size of 30 yeast strains with broken YACs. On the other
hand, Zimonjic et al., (1997) used a sample size of 448 BACs. The distribution from
Zimonjic et al., (1997) gives the best representation of the true breakage distribution along
FRA3B, because of the number of samples tested. Although I used a smaller sample size,
my breakage distribution is consistent with that reported by Zimonjic et al., (1997). Zimonjic
et al., (1997) used sequence tag sites (STS) to identify breakage events. This method of
breakage identification allowed the researchers to determine if a break occurred centromereproximal or centromere-distal to the STS. The limitation of this study is that break regions
are determined based on the distance between STSs. My study used a smaller sample size to
create a breakage distribution along FRA3B. I was able to narrow break locations
substantially further than Zimonjic et al., (1997) and could establish a smaller breakage
region for each sample, creating a more accurate breakage distribution. In order to be
confident that I truly know the extent of how much sequence of FRA3B is unstable, I would
suggest increasing the sample size of my breakage events thereby providing a larger sample
of breaks while using the technique that gives the most accurate distribution. The breaks I
mapped in the FRA3B region are not evenly distributed. Seventy percent of the breaks are
within intron 5 of the FHIT gene, with eighty-six percent of these located within a 54 kb
region. This evidence demonstrates that the FRA3B region is fragile over ~500 kb, but there
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is a hotspot for breakage within the FRA3B intron 5 at chr3: 60,442,468-60,388,667. This
hotspot location differs substantially from those discovered by Wang et al., (1997) who
identified hotspots of breakage between chr3: 60,781,743-60,781,638 and chr3: 60,576,90460,576,478. The hotspot identified by Zimonjic et al., (1997) is closer to my results, located
across FHIT exon 4 at ch3: 60807613, still centromere-proximal to the location that I
identified. Durkin et al., (2008) located a hotspot at FHIT exon 5 at chr3: 60,522,590, which
was also centromere-proximal to the location that I identified. This evidence suggests that
my breakage distribution is similar to Zimonjic et al., (1997) and Durkin et al., (2008) but
have a hotspot located centromere-distal to that previously identified. My FRA3B breakage
distribution contains breaks at both Zimonjic et al., (1997) and Durkin et al., (2008) hotspot
locations. The shift of the majority of my breaks centromere-distal to those locations could
suggest that I have identified a new hotspot for breakage that was previously unidentified.
The shift could also be attributed to using a yeast model compared to human mouse hybrid
cells or bacteria.
Common fragile site FRA7H is reported to span approximately 161 kb along
chromosome 7 from 130,670,277-130,505,797 (Hellman et al., 2000). Hellman et al., (2000)
used fork progression and replication timing to determine the fragile site. I used to the YAC
model method to identify breaks within this region to determine fragility. I identified three
breaks that were centromere-proximal and one that was centromere-distal to the reported
boundaries of FRA7H (Table 9, strains Y447, Y467, Y466, and Y464). These data suggest
that the fragile region of FRA7H is larger than previously described. As in the case of
FRA3B, breaks in the FRA7H region are not evenly distributed (Figure 22). Sixty percent of
the breaks in FRA7H are within a 45 kb region. This evidence suggests that a hotspot within
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the FRA7H fragile site is present at chr7: 130,632,701-130,587,907. The results of FRA3B
and FRA7H break distribution suggest that while fragility exists throughout the region, the
majority of breakage events happen within a small region of each fragile site.
There are two main hypotheses to explain break formation at human common fragile
sites during DNA replication stress. The first hypothesis is that fragility within the region is
due to secondary structure formation in regions of single stranded DNA near replication
forks, followed by a break at these sites under replication stress (Mishmar et al., 1998).
Regions of high DNA flexibility (“flexibility peaks”) as predicted by analyses of the twist
angle of a series of sequential base pairs (Sarai et al., 1989), have been proposed as likely
sites for secondary structure formation. The second hypothesis is that fragility within the
region is due to a lack of origins available to complete replication before mitosis. Fragile
sites contain fewer origins than non-fragile regions, and under replication stress, no
additional origins are fired in fragile site regions to help complete replication (Letessier et al.,
2011; Ozeri-Galai et al., 2011).
Previous research concerning the role of flexibility peaks in breakage at fragile sites
was contradictory (Durkin et al., 2008; Ragland et al., 2008; Rajula, 2011; Zhang and
Freudenreich, 2007). I compared the distribution of breaks within each of my fragile site
inserts with the location of flexibility peaks in the same insert. The distribution of breaks in
FRA3B is significantly correlated to locations of known flexibility peaks (Figure 26). The
average distance from the critical break areas in the 30 strains to known distal flexibility
peaks was 13,165 bp. Of the 27 breaks used in the FRA3B analysis, 30% contained
flexibility peaks within the critical break areas. This indicates that breaks not only occur
close to flexibility peaks, but in several cases, occur directly at the flexibility peak.
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However, in FRA7H the distribution of breaks was significantly further away from flexibility
peaks compared with control non-break areas. The majority of breaks within the FRA7H
insert occur directly centromere-distal to the third flexibility peak (Figure 27). Of the 29
breaks used in the FRA7H flexibility peak analysis, only 14% contained flexibility peaks
within their control break areas.
The results of the flexibility peak analysis for FRA3B and FRA7H do not agree.
These data raise the possibility that different breakage mechanisms play a role in
chromosome breakage at FRA3B and FRA7H. This evidence supports the hypothesis that
secondary structure formation may lead to breakage in FRA3B, but not in FRA7H.
Interpretation of these data are limited by the fact that flexibility peaks are identified by a
computer program and have not been tested to fully identify regions that form secondary
structures. In order to gain this information, the segments of DNA containing the flexibility
peaks would need to be transformed into a plasmid and then processed through a
denaturation and reduplexing reaction to identify if secondary structure formation potential
exists.
Next, I analyzed if the break distribution within both fragile sites was due to the
DNA’s ability to spontaneously denature. This easily denatured DNA could form a variety
structures that could stall replication fork progression and lead to breakage. Through the use
of the WebSIDD server (http://benham.genomecenter.ucdavis.edu/sibz/), I determined the
free energy needed to spontaneously denature the DNA within the flexibility peaks for both
of my fragile regions. This analysis was used to evaluate whether the FRA3B flexibility
peaks and FRA7H flexibility peaks differ in their potential to denature. I determined that
there was no difference between the free energies obtained from FRA3B flexibility peaks and
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the FRA7H flexibility peaks (Mann-Whitney U Test/Wilcoxon Rank Sum Test, two-tailed
test p=0.326078). This evidence does not help explain the difference in the data about the
role of flexibility peaks in causing breaks. Future research could look at other factors that
may play a role in the difference between the FRA3B and FRA7H flexibility peak analysis.
The flexibility peaks are identified to be AT-rich and therefore are suggested to have more
flexibility and torsion. Continued research should test the amount of AT-richness for each
flexibility peak and compare findings between FRA3B and FRA7H peaks. One could also
look at the distribution of peaks in each fragile site. FRA3B contains many flexibility peaks
that are located close to one another. Peaks that are clumped together may influence
instability due to increased secondary structure formation within a single region of DNA.
My research labeled a flexibility peak based as a single DNA bp, but each peak is comprised
of a different sequence length (Table 13 and 14). It is possible that the flexibility of each
peak is dependent on the size of that peak, with increased secondary structure formation
resulting from larger or smaller size. Future studies should look at flexibility peak size and
compare peak size of FRA3B and FRA7H peaks. These future studies could help identify
the role of flexibility peaks in causing breaks.
To further evaluate the secondary structure hypothesis, I determined whether the
break locations were in segments of DNA that could form more stable secondary structures
that could lead to fork stalling and eventual breakage. I used the mFOLD Web Server
(http://mfold.rna.albany.edu/?q=mfold/DNA-Folding-Form) to computationally analyze the
experimental critical break areas compared to a set of control non-break areas for each fragile
site. My analysis showed that in both FRA3B and FRA7H, there was no difference between
the free energies representing critical break areas compared to control non-break areas.
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Therefore, there is no evidence that the ability to form secondary structure within the critical
break areas is different from of non-break areas. Therefore, the break locations are apparently
independent of sequence content that could form more stable secondary structures, and does
not support the secondary structure hypothesis. This analysis looked at an average of a set of
critical break areas and compared it to an average from one set of non-break areas. The
conclusions derived from these data are limited due to the lack of control sets. I would
suggest completing analytical work on more control sets. By comparing my experimental set
to 100 control sets of data, one would be able to determine if the experimental set would be
more likely to have statistical significance.
Previous research suggests that a lack of origins present within the fragile site region
results in incomplete replication during replication stress and eventual breakage in mitosis
(Letessier et al., 2011; Ozeri-Galai et al., 2011; Palakodeti et al., 2010). To evaluate this
hypothesis, I identified regions of the human DNA inserts that could potentially act as yeast
origins of DNA replication. Yeast origin sites are still poorly understood, but it is known that
yeast origins contain an essential 11 bp autonomously consensus sequence (Domain A),
followed by a 100 bp domain of AT richness at the 3’ end of the consensus sequence
(Domain B). This method of identification does not positively identify a functioning yeast
origin; rather it identifies potential yeast origins. Therefore this analysis has conservatively
established a lower boundary average distance from break distributions to a possible yeast
origin site. Of the 20,000 potential ACS sites computationally identified within the yeast
genome, approximately 400 functional yeast origins have been experimentally verified
(Nieduszynski et al., 2006). The average distance between verified yeast origins for the entire
yeast genome is 34,834 bp based on the number of origins present compared to the amount of
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DNA, identified by the Saccharomyces	
  Genome	
  Database	
  (www.yeastgenome.org/).	
  
Average	
  distances	
  between	
  verified	
  yeast	
  origins	
  range	
  from	
  16,664	
  bp	
  on	
  chromosome	
  
III	
  to	
  57,436	
  bp	
  on	
  chromosome	
  XV.	
  The actual distance between breaks within the insert
and functional origins may be larger than I determined here, due to the fact that not all of the
potential origin sites I identified are likely to be used during replication. Using the consensus
sequence and AT-richness analysis, I identified potential yeast origin sites within the FRA3B
and FRA7H inserts. The average distance between potential origins was 27,478 bp in the
FRA3B analyzed insert and 19,200 bp in the FRA7H analyzed insert. I compared the
distribution of potential origins to the distribution of experimental breaks within each insert.
The results from both fragile sites are similar. The average distance from FRA3B critical
break areas to potential origins is 43,604 bp which is more than 2.5 times greater (6 standard
deviations) than the average distance determined from 100 control sets of non-break areas.
The average distance from FRA7H critical break areas to potential origins is12,907 bp which
is approximately 1.5 times greater (more than 3 standard deviations) than the average
distance determined from 100 control sets. This analysis shows that breaks within both
FRA3B and FRA7H fragile sites occur far from potential origins, supporting the hypothesis
that a lack in origin sites available to complete replication may lead to breakage. The
average distance from FRA7H critical break areas to potential origins was 12,907 bp, which
is quite small compared to the average distance of 34,834 bp between origins in the yeast
genome. Even though the experimental FRA7H distance is significantly different from the
control data set, it is still substantially smaller than normal fork progression distances. The
distance calculated between FRA7H critical break areas and potential origins is a low
boundary. Not all potential origins are functional, therefore the distance between FRA7H
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critical break areas and functional yeast origins if they were to be identified are likely to be
much larger.
As a result of the flexibility peak and origins analyses, additional analysis was
conducted to identify if other sequence characteristics might be playing a role in fragile site
breakage. I analyzed if break distributions were correlated with the addition of a telomere
cap at the double-stranded break. Telomere addition is preferential at GT-rich regions
(Kramer and Haber, 1993). Breaks could be identified at locations that would accept
telomere addition. After analyzing the GT-richness of the experimental critical break areas
compared to one control set of non-break areas, I determined that there was no difference in
GT content between the two sets of data. I also determined that there was no difference
between the GT-richness of experimental critical break areas at which telomeres were
successfully identified compared to those at which telomere addition was not determined.
This evidence suggests that identified break locations were independent of sequence content
that would support telomere addition. The conclusions derived from these data are again
limited due to the lack of control sets. I would suggest completing analytical work on more
control sets. By comparing my experimental set to 100 control sets of data, one would be
able to determine if the experimental set would be more likely to have statistical significance.
In order to further test the hypothesis that breaks occur at AT-rich flexibility peaks
that are able to form secondary structures, a new artificial yeast chromosome could be
constructed. I identified several flexibility peaks within FRA3B and FRA7H that have high
torsion angles. I would suggest developing a procedure similar to Zhang et al., (2007),
taking individual flexibility peaks and inserting them into a YAC. Zhang et al., (2007) did
not identify exact break locations. To improve on their technique, I would determine the
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break locations using the PCR procedure identified in sections 2.6-2.9. I could then
determine if breaks were occurring directly at the flexibility peaks since the analyzable insert
would be much smaller. This construct would allow testing of the hypothesis that presence
of flexibility peaks within a small segment of DNA leads to DNA breakage. The distribution
of AT-rich flexibility peaks within the FRA3B and FRA7H inserts is different. Within
FRA3B, peaks tend to cluster, whereas in FRA7H peaks are spread more widely. An
additional analysis to determine the role of secondary structure formation and breakage
within fragile sites would be to test the clustering effect of AT-rich flexibility peaks. A YAC
could be constructed using a non-fragile human DNA insert. Into this YAC, one could insert
flexibility peaks in clusters of three or four. As a control, one could evenly disperse
flexibility peaks throughout the insert. These constructs would allow testing the hypothesis
that clustered flexibility peaks with multiple secondary structures stall replication forks more
efficiently and result in more breakage than single flexibility peaks.
In order to further test the hypothesis that breaks occur in origin poor areas, it should
be determined whether human DNA sequences can function as yeast origins of replication.
The one known yeast origin located within the YAC could be deleted, and then identification
of a replicated YAC in future generations would give evidence that DNA sequences within
the human insert can function as origins of replication (pseudo-yeast origins). I would then
suggest experimental validation of functional pseudo-yeast origins within each human insert.
In order to understand if breaks are occurring furthest from origins, those origins must be
determined to be functional. Another approach for testing this hypothesis would be to modify
the current YAC to insert another known yeast origin centromere distal to the human insert.
The distribution of breaks within the FRA3B insert showed a hotspot for breakage at the
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distal end of the insert. If an additional yeast origin implanted into the YAC distal to the
insert, this may reduce the number of breaks occurring at the distal end of the insert (close to
the new origin) and increase the number congregating towards the center of the human insert.
If the breakage hotspot remained towards the distal end of the insert, this evidence would
suggest that a sequence characteristic played a role in breakage events. Flipping the
orientation of the human DNA insert within the experimental YACs could further test this
hypothesis. If the breakage of fragile site DNA was dependent on distance from origin sites,
then the break locations should shift away from the only known origin site located within the
YAC. My FRA3B break distribution showed a hotspot at the distal end of the insert. After
flipping the human insert, a shift in the distribution of breaks away from the proximal end of
the insert would support the lack of origins hypothesis whereas a distribution located within
the same region as I identified in this project would support that a sequence characteristic
played a role in breakage events.
	
  

It	
  is	
  also	
  important	
  to	
  continue	
  research	
  on	
  common	
  fragile	
  sites	
  other	
  than	
  

FRA3B	
  and	
  FRA7H.	
  Identification	
  of	
  break	
  distributions	
  within	
  several	
  different	
  fragile	
  
sites	
  using	
  the	
  yeast	
  model	
  mechanism	
  that	
  I	
  employed	
  in	
  this	
  project	
  will	
  give	
  a	
  better	
  
picture	
  of	
  the	
  mechanism	
  for	
  breakage	
  at	
  common	
  fragile	
  sites.	
  Breakage	
  events	
  within	
  
non-‐fragile	
  human	
  DNA	
  under	
  the	
  same	
  experimental	
  conditions	
  should	
  also	
  be	
  
analyzed.	
  	
  This	
  analysis	
  could	
  create	
  a	
  baseline	
  breakage	
  frequency	
  to	
  compare	
  against	
  
when	
  analyzing	
  additional	
  fragile	
  sites.	
  	
  Evidence	
  from	
  the	
  breakage	
  patterns	
  in	
  a	
  
multitude	
  of	
  common	
  fragile	
  sites	
  could	
  lend	
  support	
  for	
  either	
  of	
  the	
  two	
  proposed	
  
hypotheses,	
  suggesting	
  a	
  significant	
  pathway	
  to	
  pursue.	
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In summary, the results presented here give valuable insight to the mechanism of
DNA breakage that takes place within fragile sites FRA3B and FRA7H. I have identified 30
breakage events in each fragile site and located a hotspot within each of these fragile sites of
approximately 60 kb at which the majority of breaks accumulate. My analysis of these break
locations suggests that the lack of origins available to complete replication plays a role in
breakage events within both FRA3B and FRA7H. The results also suggest the possibility
that secondary structure formation at AT-rich flexibility peaks could contribute to breakage
within the common fragile site FRA3B but is unlikely to contribute to breakage within
common fragile site FRA7H.
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